 | Up a level |
Seubnooch, Patcharamon; Montani, Matteo; Dufour, Jean-François; Masoodi, Mojgan (2024). Spatial lipidomics reveals zone-specific hepatic lipid alteration and remodeling in Metabolic dysfunction-associated steatohepatitis. Journal of lipid research, 65(9), p. 100599. Elsevier 10.1016/j.jlr.2024.100599
Tsouka, Sofia; Kumar, Pavitra; Seubnooch, Patcharamon; Freiburghaus, Katrin; St-Pierre, Marie; Dufour, Jean-François; Masoodi, Mojgan (2024). Transcriptomics-driven metabolic pathway analysis reveals similar alterations in lipid metabolism in mouse MASH model and human. Communications medicine, 4(39) Springer Nature 10.1038/s43856-024-00465-3
Toyoda, Hidenori; Kanneganti, Mounika; Melendez-Torres, Jonathan; Parikh, Neehar D; Jalal, Prasun K; Piñero, Federico; Mendizabal, Manuel; Ridruejo, Ezequiel; Cheinquer, Hugo; Casadei-Gardini, Andrea; Weinmann, Arndt; Peck-Radosavljevic, Markus; Dufour, Jean-François; Radu, Pompilia; Shiha, Gamal; Soliman, Riham; Sarin, Shiv K; Kumar, Manoj; Wang, Jing-Houng; Tangkijvanich, Pisit; ... (2024). Regional differences in clinical presentation and prognosis of patients with post-sustained virologic response (SVR) hepatocellular carcinoma. Clinical gastroenterology and hepatology, 22(1), 72-80.e4. Elsevier 10.1016/j.cgh.2023.06.026
McTeer, Matthew; Applegate, Douglas; Mesenbrink, Peter; Ratziu, Vlad; Schattenberg, Jörn M; Bugianesi, Elisabetta; Geier, Andreas; Romero Gomez, Manuel; Dufour, Jean-Francois; Ekstedt, Mattias; Francque, Sven; Yki-Jarvinen, Hannele; Allison, Michael; Valenti, Luca; Miele, Luca; Pavlides, Michael; Cobbold, Jeremy; Papatheodoridis, Georgios; Holleboom, Adriaan G; Tiniakos, Dina; ... (2024). Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information. PLoS ONE, 19(2), e0299487. Public Library of Science 10.1371/journal.pone.0299487
Vali, Yasaman; Lee, Jenny; Boursier, Jerome; Petta, Salvatore; Wonders, Kristy; Tiniakos, Dina; Bedossa, Pierre; Geier, Andreas; Francque, Sven; Allison, Mike; Papatheodoridis, Georgios; Cortez-Pinto, Helena; Pais, Raluca; Dufour, Jean-Francois; Leeming, Diana Julie; Harrison, Stephen A; Chen, Yu; Cobbold, Jeremy F; Pavlides, Michael; Holleboom, Adriaan G; ... (2023). Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study. The lancet. Gastroenterology & hepatology, 8(8), pp. 714-725. Elsevier 10.1016/S2468-1253(23)00017-1
Lee, Jenny; Westphal, Max; Vali, Yasaman; Boursier, Jerome; Ostroff, Rachel; Alexander, Leigh; Chen, Yu; Fournier, Celine; Geier, Andreas; Francque, Sven; Wonders, Kristy; Tiniakos, Dina; Bedossa, Pierre; Allison, Mike; Papatheodoridis, Georgios; Cortez-Pinto, Helena; Pais, Raluca; Dufour, Jean-François; Leeming, Diana Julie; Harrison, Stephen; ... (2023). Machine learning algorithm improves detection of NASH (NAS-based) and at-risk NASH, a development and validation study. Hepatology, 78(1), pp. 258-271. Wiley 10.1097/HEP.0000000000000364
Seubnooch, Patcharamon; Montani, Matteo; Tsouka, Sofia; Claude, Emmanuelle; Rafiqi, Umara; Perren, Aurel; Dufour, Jean-Francois; Masoodi, Mojgan (2023). Characterisation of hepatic lipid signature distributed across the liver zonation using mass spectrometry imaging. JHEP reports, 5(6), p. 100725. Elsevier 10.1016/j.jhepr.2023.100725
Dirchwolf, Melisa; Becchetti, Chiara; Stampf, Susanne; Haldimann, Christa; Immer, Franz; Beyeler, Franziska; Toso, Christian; Dutkowski, Philipp; Candinas, Daniel; Dufour, Jean-Francois; Banz, Vanessa (2023). The impact of perceived donor liver quality on post-transplant outcome. ANZ journal of surgery, 93(4), pp. 918-925. Wiley 10.1111/ans.18217
Becchetti, Chiara; Lange, Naomi F; Delgado, Maria Gabriela; Brönnimann, Michael P; Maurer, Martin H; Dufour, Jean-François; Berzigotti, Annalisa (2023). 2D shear wave elastography of the rectus femoris muscle in patients with cirrhosis: feasibility and clinical findings. A pilot study. Clinics and research in hepatology and gastroenterology, 47(3), p. 102080. Elsevier Masson 10.1016/j.clinre.2023.102080
Zhang, Huai; Rios, Rafael S; Boursier, Jerome; Anty, Rodolphe; Chan, Wah-Kheong; George, Jacob; Yilmaz, Yusuf; Wong, Vincent Wai-Sun; Fan, Jiangao; Dufour, Jean-François; Papatheodoridis, George; Chen, Li; Schattenberg, Jörn M; Shi, Jun-Ping; Xu, Liang; Wong, Grace Lai-Hung; Lange, Naomi F; Papatheodoridi, Margarita; Mi, Yuqiang; Zhou, Yujie; ... (2023). Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study. Chinese medical journal, 136(3), pp. 341-350. Wolters Kluwer 10.1097/CM9.0000000000002603
Buch, Stephan; Innes, Hamish; Lutz, Philipp Ludwig; Nischalke, Hans Dieter; Marquardt, Jens U; Fischer, Janett; Weiss, Karl Heinz; Rosendahl, Jonas; Marot, Astrid; Krawczyk, Marcin; Casper, Markus; Lammert, Frank; Eyer, Florian; Vogel, Arndt; Marhenke, Silke; von Felden, Johann; Sharma, Rohini; Atkinson, Stephen Rahul; McQuillin, Andrew; Nattermann, Jacob; ... (2023). Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study. Gut, 72(2), pp. 381-391. BMJ Publishing Group 10.1136/gutjnl-2022-327196
Scheiner, Bernhard; Roessler, Daniel; Phen, Samuel; Lim, Mir; Pomej, Katharina; Pressiani, Tiziana; Cammarota, Antonella; Fründt, Thorben W.; von Felden, Johann; Schulze, Kornelius; Himmelsbach, Vera; Finkelmeier, Fabian; Deibel, Ansgar; Siebenhüner, Alexander R.; Shmanko, Kateryna; Radu, Pompilia; Schwacha-Eipper, Birgit; Ebert, Matthias P.; Teufel, Andreas; Djanani, Angela; ... (2023). Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma. JHEP reports, 5(1), p. 100620. Elsevier 10.1016/j.jhepr.2022.100620
Haber, Philipp K; Castet, Florian; Torres-Martin, Miguel; Andreu-Oller, Carmen; Puigvehí, Marc; Maeda, Miho; Radu, Pompilia; Dufour, Jean-Francois; Verslype, Chris; Czauderna, Carolin; Marquardt, Jens U; Galle, Peter R; Vogel, Arndt; Bathon, Melanie; Meyer, Tim; Labgaa, Ismail; Digklia, Antonia; Roberts, Lewis R; Mohamed Ali, Mohamed A; Mínguez, Beatriz; ... (2023). Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma. Gastroenterology, 164(1), 72-88.e18. Elsevier 10.1053/j.gastro.2022.09.005
Dufour, Jean-François; Marjot, Thomas; Becchetti, Chiara; Tilg, Herbert (2022). COVID-19 and liver disease. Gut, 71(11), pp. 2350-2362. BMJ Publishing Group 10.1136/gutjnl-2021-326792
Radu, Pompilia; Ebadi, Maryam; Montano-Loza, Aldo J; Dufour, Jean François (2022). What Is the Role of Body Composition Assessment in HCC Management? Cancers, 14(21) MDPI AG 10.3390/cancers14215290
Becchetti, Chiara; Dirchwolf, Melisa; Schropp, Jonas; Magini, Giulia; Müllhaupt, Beat; Immer, Franz; Dufour, Jean-François; Banz, Vanessa; Berzigotti, Annalisa; Bosch, Jaime (2022). Use of statins after liver transplantation is associated with improved survival: results of a nationwide study. Alimentary pharmacology & therapeutics, 56(7), pp. 1194-1204. Wiley-Blackwell 10.1111/apt.17192
Jin, Chaonan; Felli, Eric; Lange, Naomi Franziska; Berzigotti, Annalisa; Jordi, Gracia-Sancho; Dufour, Jean-François (2022). Endoplasmic Reticulum and Mitochondria Contacts Correlate with the Presence and Severity of NASH in Humans. International journal of molecular sciences, 23(15) MDPI 10.3390/ijms23158348
Gracia-Sancho, Jorge; Dufour, Jean-François (2022). NTCP: a pharmacological target for multiple liver conditions. Gut, 71(7), pp. 1248-1250. BMJ Publishing Group 10.1136/gutjnl-2021-325917
Reynard, Maxence Emmanuel; Dufour, Jean-François (2022). Elective percutaneous liver biopsy and use of aspirin. United European gastroenterology journal, 10(6), pp. 538-543. Wiley 10.1002/ueg2.12254
Guixé-Muntet, Sergi; Biquard, Louise; Szabo, Gyongyi; Dufour, Jean-François; Tacke, Frank; Francque, Sven; Rautou, Pierre-Emmanuel; Gracia-Sancho, Jordi (2022). Review: Vascular effects of PPARs in the context of NASH. Alimentary pharmacology & therapeutics, 56(2), pp. 209-223. Wiley-Blackwell 10.1111/apt.17046
Dirchwolf, Melisa; Becchetti, Chiara; Gschwend, Sarah G; Toso, Christian; Dutkowski, Philipp; Immer, Franz; Beyeler, Franziska; Rossi, Simona; Schropp, Jonas; Dufour, Jean-François; Banz, Vanessa (2022). The MELD upgrade exception: a successful strategy to optimize access to liver transplantation for patients with high waiting list mortality. HPB : official journal of The International Hepato-Pancreato-Biliary Association, 24(7), pp. 1168-1176. Elsevier 10.1016/j.hpb.2021.12.009
Terrault, Norah A; Dufour, Jean-François; Schwabe, Robert F; Wong, Vincent Wai-Sun (2022). Breakthroughs in hepatology. Journal of hepatology, 76(6), pp. 1247-1248. Elsevier 10.1016/j.jhep.2022.04.001
Méndez-Sánchez, Nahum; Bugianesi, Elisabetta; Gish, Robert G; Lammert, Frank; Tilg, Herbert; Nguyen, Mindie H; Sarin, Shiv K; Fabrellas, Núria; Zelber-Sagi, Shira; Fan, Jian-Gao; Shiha, Gamal; Targher, Giovanni; Zheng, Ming-Hua; Chan, Wah-Kheong; Vinker, Shlomo; Kawaguchi, Takumi; Castera, Laurent; Yilmaz, Yusuf; Korenjak, Marko; Spearman, C Wendy; ... (2022). Global multi-stakeholder endorsement of the MAFLD definition. The lancet. Gastroenterology & hepatology, 7(5), pp. 388-390. Elsevier 10.1016/S2468-1253(22)00062-0
Govaere, Olivier; Petersen, Sine Kragh; Martinez-Lopez, Nuria; Wouters, Jasper; Van Haele, Matthias; Mancina, Rosellina M; Jamialahmadi, Oveis; Bilkei-Gorzo, Orsolya; Lassen, Pierre Bel; Darlay, Rebecca; Peltier, Julien; Palmer, Jeremy M; Younes, Ramy; Tiniakos, Dina; Aithal, Guruprasad P; Allison, Michael; Vacca, Michele; Göransson, Melker; Berlinguer-Palmini, Rolando; Clark, James E; ... (2022). Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. Journal of hepatology, 76(5), pp. 1001-1012. Elsevier 10.1016/j.jhep.2021.12.012
Sapena, Victor; Enea, Marco; Torres, Ferran; Celsa, Ciro; Rios, Jose; Rizzo, Giacomo Emanuele Maria; Nahon, Pierre; Mariño, Zoe; Tateishi, Ryosuke; Minami, Tatsuya; Sangiovanni, Angelo; Forns, Xavier; Toyoda, Hidenori; Brillanti, Stefano; Conti, Fabio; Degasperi, Elisabetta; Yu, Ming-Lung; Tsai, Pei-Chien; Jean, Kevin; El Kassas, Mohamed; ... (2022). Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis. Gut, 71(3), pp. 593-604. BMJ Publishing Group 10.1136/gutjnl-2020-323663
Rinella, Mary; Dufour, Jean-François; Anstee, Quentin M; Goodman, Zachary; Younossi, Zobair; Harrison, Stephen A; Loomba, Rohit; Sanyal, Arun J; Bonacci, Martin; Trylesinski, Aldo; Natha, Macky; Shringarpure, Reshma; Granston, Tanya; Venugopal, Aditya; Ratziu, Vlad (2022). Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study. Journal of hepatology, 76(3), pp. 536-548. Elsevier 10.1016/j.jhep.2021.10.029
Riebensahm, C.; Chitundu, H.; Muula, G.; Chihota, B.; Sinkala, E.; Sunkutu, V.; Maurer, Martin; Dufour, J. F.; Berzigotti, A.; Egger, M.; Bolton-Moore, C.; Vinikoor, M.; Wandeler, G. (2022). Screening for Hepatocellular Carcinoma among adults with HIV/Hepatitis B coinfection in Zambia: A Pilot Study. International journal of infectious diseases, 116, pp. 391-396. Elsevier 10.1016/j.ijid.2021.12.338
Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M; Hucke, Florian; Finkelmeier, Fabian; Waidmann, Oliver; Himmelsbach, Vera; Schulze, Kornelius; von Felden, Johann; Fründt, Thorben W; Stadler, Marc; Heinzl, Harald; Shmanko, Kateryna; Spahn, Stephan; Radu, Pompilia; Siebenhüner, Alexander R; Mertens, Joachim C; Rahbari, Nuh N; Kütting, Fabian; Waldschmidt, Dirk-Thomas; ... (2022). Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score. Journal of hepatology, 76(2), pp. 353-363. Elsevier 10.1016/j.jhep.2021.09.035
Bihl, Florian; Bruggmann, Philip; Castro Batänjer, Erika; Dufour, Jean-François; Lavanchy, Daniel; Müllhaupt, Beat; Negro, Francesco; Razavi, Homie; Scheidegger, Claude; Semela, David; Semmo, Nasser; Blach, Sarah (2022). HCV disease burden and population segments in Switzerland. Liver international, 42(2), pp. 330-339. Wiley 10.1111/liv.15111
Mendoza, Yuly P.; G. Rodrigues, Susana; Delgado, Maria G.; Murgia, Giuseppe; Lange, Naomi F.; Schropp, Jonas; Montani, Matteo; Dufour, Jean-François; Berzigotti, Annalisa (2022). Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease. Liver international, 42(1), pp. 102-111. Wiley 10.1111/liv.15116
Becchetti, Chiara; Broekhoven, Annelotte G C; Dahlqvist, Géraldine; Fraga, Montserrat; Zambelli, Marco Fabrizio; Ciccarelli, Olga; Saouli, Anne-Catherine; Trizzino, Arianna; Banz Wüthrich, Vanessa; Dufour, Jean-François; Roukens, Anna H E; Torres Morales, Shessy P; Myeni, Sebenzile K; Kikkert, Marjolein; Feltkamp, Mariet C W; Coenraad, Minneke J (2022). Humoral response to SARS-CoV-2 infection among liver transplant recipients. Gut, 71(4), pp. 746-756. BMJ Publishing Group 10.1136/gutjnl-2021-326609
Radu, Iuliana-Pompilia; Dufour, Jean-François (2022). Sonography in surveillance for HCC in NAFLD patients. Hepatoma research, 8, p. 38. OAE Publishing 10.20517/2394-5079.2022.42
Trueb, Beat; Zhuang, Lei; Keller, Irene; von Köckritz, Leona; Kuchen, Stefan; Dufour, Jean-François; Villiger, Peter (2021). Coincidence of NOD2-Associated Autoinflammatory Disease (Yao Syndrome) and HCV Infection With Fatal Consequences: Interaction Between Genes and Environment. Journal of clinical rheumatology, 27(8S), S592-S594. Wolters Kluwer Health 10.1097/RHU.0000000000000963
Pinyol, Roser; Torrecilla, Sara; Wang, Huan; Montironi, Carla; Piqué-Gili, Marta; Torres-Martin, Miguel; Wei-Qiang, Leow; Willoughby, Catherine E; Ramadori, Pierluigi; Andreu-Oller, Carmen; Taik, Patricia; Lee, Youngmin A; Moeini, Agrin; Peix, Judit; Faure-Dupuy, Suzanne; Riedl, Tobias; Schuehle, Svenja; Oliveira, Claudia P; Alves, Venancio A; Boffetta, Paolo; ... (2021). Corrigendum to 'Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis' [J Hepatol 75 (2021) 865-878]. Journal of hepatology, 75(6), p. 1515. Elsevier 10.1016/j.jhep.2021.09.014
Masoodi, Mojgan; Gastaldelli, Amalia; Hyötyläinen, Tuulia; Arretxe, Enara; Alonso, Cristina; Gaggini, Melania; Brosnan, Julia; Anstee, Quentin M; Millet, Oscar; Ortiz, Pablo; Mato, Jose M; Dufour, Jean-François; Orešič, Matej (2021). Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. Nature reviews, 18(12), pp. 835-856. Springer Nature 10.1038/s41575-021-00502-9
Lange, Naomi F.; Radu, Pompilia; Dufour, Jean-François (2021). Prevention of NAFLD-associated HCC: role of lifestyle and chemoprevention. Journal of hepatology, 75(5), pp. 1217-1227. Elsevier 10.1016/j.jhep.2021.07.025
Correia de Sousa, Marta; Calo, Nicolas; Sobolewski, Cyril; Gjorgjieva, Monika; Clément, Sophie; Maeder, Christine; Dolicka, Dobrochna; Fournier, Margot; Vinet, Laurent; Montet, Xavier; Dufour, Jean-François; Humar, Bostjan; Negro, Francesco; Sempoux, Christine; Foti, Michelangelo (2021). Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis. Cancers, 13(19) MDPI AG 10.3390/cancers13194983
Pinyol, Roser; Torrecilla, Sara; Wang, Huan; Montironi, Carla; Piqué-Gili, Marta; Torres-Martin, Miguel; Wei-Qiang, Leow; Willoughby, Catherine E; Ramadori, Pierluigi; Andreu-Oller, Carmen; Taik, Patricia; Lee, Youngmin A; Moeini, Agrin; Peix, Judit; Faure-Dupuy, Suzanne; Riedl, Tobias; Schuehle, Svenja; Oliveira, Claudia P; Alves, Venancio A; Boffetta, Paolo; ... (2021). Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. Journal of hepatology, 75(4), pp. 865-878. Elsevier 10.1016/j.jhep.2021.04.049
Becchetti, Chiara; Gschwend, Sarah Gabriela; Dufour, Jean-François; Banz Wüthrich, Vanessa (2021). COVID-19 in Liver Transplant Recipients: A Systematic Review. Journal of clinical medicine, 10(17) MDPI 10.3390/jcm10174015
Moser, Monika; Radu, Iuliana-Pompilia; Dufour, Jean-François (2021). Effects of Home Care on patients with hepatocellular carcinoma treated with sorafenib. JGH open, 5(8), pp. 864-870. Wiley 10.1002/jgh3.12533
Finkelmeier, Fabian; Scheiner, Bernhard; Leyh, Catherine; Best, Jan; Fründt, Thorben Wilhelm; Czauderna, Carolin; Beutel, Alica; Bettinger, Dominik; Weiß, Johannes; Meischl, Tobias; Kütting, Fabian; Waldschmidt, Dirk-Thomas; Radu, Pompilia; Schultheiß, Michael; Peiffer, Kai-Henrik; Ettrich, Thomas J; Weinmann, Arndt; Wege, Henning; Venerito, Marino; Dufour, Jean-François; ... (2021). Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort. Liver cancer, 10(4), pp. 360-369. Karger 10.1159/000515490
Mendoza, Yuly P.; Becchetti, Chiara; Wan, Tao; Nett, Philipp; Rodrigues, Susana G.; Dufour, Jean-François; Berzigotti, Annalisa (2021). Malnutrition and Alcohol in Patients Presenting with Severe Complications of Cirrhosis After Laparoscopic Bariatric Surgery. Obesity surgery, 31(6), pp. 2817-2822. Springer-Verlag 10.1007/s11695-021-05237-9
Jin, Chaonan; Kumar, Pavitra; Gracia-Sancho, Jorge; Dufour, Jean-François (2021). Calcium transfer between endoplasmic reticulum and mitochondria in liver diseases. FEBS letters, 595(10), pp. 1411-1421. FEBS Press 10.1002/1873-3468.14078
Anstee, Quentin M; Darlay, Rebecca; Cockell, Simon; Meroni, Marica; Govaere, Olivier; Tiniakos, Dina; Burt, Alastair D; Bedossa, Pierre; Palmer, Jeremy; Liu, Yang-Lin; Aithal, Guruprasad P; Allison, Michael; Yki-Järvinen, Hannele; Vacca, Michele; Dufour, Jean-François; Invernizzi, Pietro; Prati, Daniele; Ekstedt, Mattias; Kechagias, Stergios; Francque, Sven; ... (2021). Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505-515). Journal of hepatology, 74(5), pp. 1274-1275. Elsevier 10.1016/j.jhep.2021.02.003
Dudek, Michael; Pfister, Dominik; Donakonda, Sainitin; Filpe, Pamela; Schneider, Annika; Laschinger, Melanie; Hartmann, Daniel; Hüser, Norbert; Meiser, Philippa; Bayerl, Felix; Inverso, Donato; Wigger, Jennifer; Sebode, Marcial; Öllinger, Rupert; Rad, Roland; Hegenbarth, Silke; Anton, Martina; Guillot, Adrien; Bowman, Andrew; Heide, Danijela; ... (2021). Author Correction: Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH. Nature, 593(7860), E14. Springer Nature 10.1038/s41586-021-03568-2
von Hessen, Leona; Roumet, Marie; Maurer, Martin; Lange, Naomi; Reeves, Helen; Dufour, Jean-François; Radu, Pompilia (2021). High subcutaneous adipose tissue density correlates negatively with survival in patients with hepatocellular carcinoma. Liver international, 41(4), pp. 828-836. Wiley 10.1111/liv.14755
R Galle, Peter; Dufour, Jean-François; Peck-Radosavljevic, Markus; Trojan, Jörg; Vogel, Arndt (2021). Systemic therapy of advanced hepatocellular carcinoma. Future oncology, 17(10), pp. 1237-1251. Future Medicine Ltd. 10.2217/fon-2020-0758
Pfister, Dominik; Núñez, Nicolás Gonzalo; Pinyol, Roser; Govaere, Olivier; Pinter, Matthias; Szydlowska, Marta; Gupta, Revant; Qiu, Mengjie; Deczkowska, Aleksandra; Weiner, Assaf; Müller, Florian; Sinha, Ankit; Friebel, Ekaterina; Engleitner, Thomas; Lenggenhager, Daniela; Moncsek, Anja; Heide, Danijela; Stirm, Kristin; Kosla, Jan; Kotsiliti, Eleni; ... (2021). NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature, 592(7854), pp. 450-456. Springer Nature 10.1038/s41586-021-03362-0
Dudek, Michael; Pfister, Dominik; Donakonda, Sainitin; Filpe, Pamela; Schneider, Annika; Laschinger, Melanie; Hartmann, Daniel; Hüser, Norbert; Meiser, Philippa; Bayerl, Felix; Inverso, Donato; Wigger, Jennifer; Sebode, Marcial; Öllinger, Rupert; Rad, Roland; Hegenbarth, Silke; Anton, Martina; Guillot, Adrien; Bowman, Andrew; Heide, Danijela; ... (2021). Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH. Nature, 592(7854), pp. 444-449. Springer Nature 10.1038/s41586-021-03233-8
Juanola, Oriol; Hassan, Mohsin; Kumar, Pavitra; Yilmaz, Bahtiyar; Keller, Irene; Simillion, Cedric; Engelmann, Cornelius; Tacke, Frank; Dufour, Jean-François; De Gottardi, Andrea; Moghadamrad, Sheida (2021). Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns. Gut microbes, 13(1), pp. 1-20. Taylor & Francis Group 10.1080/19490976.2021.1911534
Eldafashi, Nardeen; Darlay, Rebecca; Shukla, Ruchi; McCain, Misti Vanette; Watson, Robyn; Liu, Yang Lin; McStraw, Nikki; Fathy, Moustafa; Fawzy, Michael Atef; Zaki, Marco Y W; Daly, Ann K; Maurício, João P; Burt, Alastair D; Haugk, Beate; Cordell, Heather J; Bianco, Cristiana; Dufour, Jean-François; Valenti, Luca; Anstee, Quentin M and Reeves, Helen L (2021). A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC? Cancers, 13(6) MDPI AG 10.3390/cancers13061412
Francque, Sven; Szabo, Gyongyi; Abdelmalek, Manal F; Byrne, Christopher D; Cusi, Kenneth; Dufour, Jean-François; Roden, Michael; Sacks, Frank; Tacke, Frank (2021). Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors. Nature reviews - gastroenterology & hepatology, 18(1), pp. 24-39. Nature Publishing Group 10.1038/s41575-020-00366-5
Shiha, Gamal; Korenjak, Marko; Eskridge, Wayne; Casanovas, Teresa; Velez-Moller, Patricia; Högström, Sari; Richardson, Ben; Munoz, Christopher; Sigurðardóttir, Sólveig; Coulibaly, Alioune; Milan, Miskovikj; Bautista, Fabiana; Leung, Nancy Wai Yee; Mooney, Vicki; Obekpa, Solomon; Bech, Eva; Polavarapu, Naveen; Hamed, Abd Elkhalek; Radiani, Temur; Purwanto, Edhie; ... (2021). Redefining fatty liver disease: an international patient perspective. The lancet. Gastroenterology & hepatology, 6(1), pp. 73-79. Elsevier 10.1016/S2468-1253(20)30294-6
Vuille-Lessard, Élise; Lange, Franziska; Riebensahm, Carlotta; Dufour, Jean-François; Berzigotti, Annalisa (2021). Dietary Interventions in Liver Diseases: Focus onMAFLD and Cirrhosis. Current hepatology reports, 20(2), pp. 61-76. Springer 10.1007/s11901-021-00563-z
Delgado, Maria Gabriela; Casu, Stefania; Montani, Matteo; Brunner, Felix; Semmo, Nasser; Berzigotti, Annalisa; Dufour, Jean-François (2021). Hepatic manifestations of drug reaction with eosinophilia and systemic symptoms syndrome. Exploration of medicine, 2, pp. 122-134. Open Exploration Publishing 10.37349/emed.2021.00037
Sparchez, Zeno; Radu, Pompilia; Bartos, Adrian; Nenu, Iuliana; Craciun, Rares; Mocan, Tudor; Horhat, Adelina; Spârchez, Mihaela; Dufour, Jean-François (2021). Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines? World journal of gastrointestinal oncology, 13(12), pp. 1896-1918. Baishideng Publishing Group 10.4251/wjgo.v13.i12.1896
Spahn, Stephan; Roessler, Daniel; Radu, Pompilia; Gabernet, Gisela; Gladstone, Beryl Primrose; Horger, Marius; Biskup, Saskia; Feldhahn, Magdalena; Nahnsen, Sven; Hilke, Franz J; Scheiner, Bernhard; Dufour, Jean-François; De Toni, Enrico N; Pinter, Matthias; Malek, Nisar P; Bitzer, Michael (2020). Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma. Cancers, 12(12) MDPI AG 10.3390/cancers12123830
Hardy, Timothy; Wonders, Kristy; Younes, Ramy; Aithal, Guruprasad P; Aller, Rocio; Allison, Michael; Bedossa, Pierre; Betsou, Fay; Boursier, Jerome; Brosnan, M Julia; Burt, Alastair; Cobbold, Jeremy; Cortez-Pinto, Helena; Day, Chris P; Dufour, Jean-François; Ekstedt, Mattias; Francque, Sven; Harrison, Stephen; Miele, Luca; Nasr, Patrik; ... (2020). The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease. Contemporary clinical trials, 98, p. 106175. Elsevier 10.1016/j.cct.2020.106175
Dufour, Jean-François; Caussy, Cyrielle; Loomba, Rohit (2020). Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges. Gut, 69(10), pp. 1877-1884. BMJ Publishing Group 10.1136/gutjnl-2019-319104
Schwacha-Eipper, Birgit; Minciuna, Iulia; Banz, Vanessa; Dufour, Jean-François (2020). Immunotherapy as a downstaging therapy for liver transplantation. Hepatology, 72(4), pp. 1488-1490. Wiley 10.1002/hep.31234
Becchetti, Chiara; Zambelli, Marco Fabrizio; Pasulo, Luisa; Donato, Maria Francesca; Invernizzi, Federica; Detry, Olivier; Dahlqvist, Géraldine; Ciccarelli, Olga; Morelli, Maria Cristina; Fraga, Montserrat; Svegliati-Baroni, Gianluca; van Vlierberghe, Hans; Coenraad, Minneke J; Romero, Mario Cristobal; de Gottardi, Andrea; Toniutto, Pierluigi; Del Prete, Luca; Abbati, Claudia; Samuel, Didier; Pirenne, Jacques; ... (2020). COVID-19 in an international European liver transplant recipient cohort. Gut, 69(10), pp. 1832-1840. BMJ Publishing Group 10.1136/gutjnl-2020-321923
Sobolewski, Cyril; Abegg, Daniel; Berthou, Flavien; Dolicka, Dobrochna; Calo, Nicolas; Sempoux, Christine; Fournier, Margot; Maeder, Christine; Ay, Anne-Sophie; Clavien, Pierre-Alain; Humar, Bostjan; Dufour, Jean-François; Adibekian, Alexander; Foti, Michelangelo (2020). S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development. Gut, 69(10), pp. 1841-1854. BMJ Publishing Group 10.1136/gutjnl-2019-319019
Guixé Muntet, Sergi; Ortega-Ribera, Martí; Wang, Cong; Selicean, Sonia; Andreu, Ion; Kechagia, Jenny Z; Fondevila, Constantino; Roca-Cusachs, Pere; Dufour, Jean-François; Bosch, Jaime; Berzigotti, Annalisa; Gracia Sancho, Jordi (2020). Nuclear deformation mediates liver cell mechanosensing in cirrhosis. JHEP reports, 2(5), p. 100145. Elsevier 10.1016/j.jhepr.2020.100145
Anstee, Quentin M; Darlay, Rebecca; Cockell, Simon; Meroni, Marica; Govaere, Olivier; Tiniakos, Dina; Burt, Alastair D; Bedossa, Pierre; Palmer, Jeremy; Liu, Yang-Lin; Aithal, Guruprasad P; Allison, Michael; Yki-Järvinen, Hannele; Vacca, Michele; Dufour, Jean-François; Invernizzi, Pietro; Prati, Daniele; Ekstedt, Mattias; Kechagias, Stergios; Francque, Sven; ... (2020). Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆. Journal of hepatology, 73(3), pp. 505-515. Elsevier 10.1016/j.jhep.2020.04.003
Lange, Naomi; Dufour, Jean-François; Berzigotti, Annalisa; Rodrigues, Susana G. (27 August 2020). Body composition parameters predict outcomes of acute kidney injury in patients with cirrhosis. Journal of hepatology, 73(Suppl. 1), S746-S746. Elsevier 10.1016/S0168-8278(20)31941-3
Radu, Pompilia; Dufour, Jean-François (2020). Changing TACTICS in intermediate HCC: TACE plus sorafenib. Gut, 69(8), pp. 1374-1376. BMJ Publishing Group 10.1136/gutjnl-2020-320692
Stickel, Felix; Lutz, Philipp; Buch, Stephan; Nischalke, Hans Dieter; Silva, Ines; Rausch, Vanessa; Fischer, Janett; Weiss, Karl Heinz; Gotthardt, Daniel; Rosendahl, Jonas; Marot, Astrid; Elamly, Mona; Krawczyk, Marcin; Casper, Markus; Lammert, Frank; Buckley, Thomas Wm; McQuillin, Andrew; Spengler, Ulrich; Eyer, Florian; Vogel, Arndt; ... (2020). Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers. Hepatology, 72(1), pp. 88-102. Wiley 10.1002/hep.30996
Eslam, Mohammed; Newsome, Philip N; Sarin, Shiv K; Anstee, Quentin M; Targher, Giovanni; Romero-Gomez, Manuel; Zelber-Sagi, Shira; Wai-Sun Wong, Vincent; Dufour, Jean-François; Schattenberg, Jörn M; Kawaguchi, Takumi; Arrese, Marco; Valenti, Luca; Shiha, Gamal; Tiribelli, Claudio; Yki-Järvinen, Hannele; Fan, Jian-Gao; Grønbæk, Henning; Yilmaz, Yusuf; Cortez-Pinto, Helena; ... (2020). A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. Journal of hepatology, 73(1), pp. 202-209. Elsevier 10.1016/j.jhep.2020.03.039
Guarino, Maria; Kumar, Pavitra; Felser, Andrea; Terracciano, Luigi M; Guixé-Muntet, Sergi; Humar, Bostjan; Foti, Michelangelo; Nuoffer, Jean-Marc; St-Pierre, Marie V.; Dufour, Jean-François (2020). Exercise Attenuates the Transition from Fatty Liver to Steatohepatitis and Reduces Tumor Formation in Mice. Cancers, 12(6) MDPI AG 10.3390/cancers12061407
Becchetti, Chiara; Dirchwolf, Melisa; Banz Wüthrich, Vanessa; Dufour, Jean-François (2020). Medical management of metabolic and cardiovascular complications after liver transplantation. World journal of gastroenterology, 26(18), pp. 2138-2154. WJG Press 10.3748/wjg.v26.i18.2138
Piccinni, Rosangela; G. Rodrigues, Susana; Montani, Matteo; Murgia, Giuseppe; Delgado, Maria G.; Casu, Stefania; Stirnimann, Guido; Semmo, Nasser; De Gottardi, Andrea; Dufour, Jean-François; Berzigotti, Annalisa (2020). Controlled Attenuation Parameter reflects steatosis in compensated advanced chronic liver disease. Liver international, 40(5), pp. 1151-1158. Wiley 10.1111/liv.14325
Tang, Kuo-Tung; Dufour, Jean-François; Chen, Po-Hung; Hernaez, Ruben; Hutfless, Susan (2020). Antitumour necrosis factor-α agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort. BMJ open gastroenterolog, 7(1), e000349. BMJ Publishing Group 10.1136/bmjgast-2019-000349
Avila, Matias A; Dufour, Jean-François; Gerbes, Alexander L; Zoulim, Fabien; Bataller, Ramon; Burra, Patrizia; Cortez-Pinto, Helena; Gao, Bin; Gilmore, Ian; Mathurin, Philippe; Moreno, Christophe; Poznyak, Vladimir; Schnabl, Bernd; Szabo, Gyongyi; Thiele, Maja; Thursz, Mark R (2020). Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting. Gut, 69(4), pp. 764-780. BMJ Publishing Group 10.1136/gutjnl-2019-319720
Kim, Hwi Young; Dufour, Jean-François (2020). Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma. Clinical and molecular hepatology, 26(2), pp. 238-239. 10.3350/cmh.2020.0051
Linecker, Michael; Frick, Lukas; Kron, Philipp; Limani, Perparim; Kambakamba, Patryk; Tschuor, Christoph; Langiewicz, Magda; Kachaylo, Ekaterina; Tian, Yinghua; Schneider, Marcel A; Ungethüm, Udo; Calo, Nicolas; Foti, Michelangelo; Dufour, Jean-François; Graf, Rolf; Humar, Bostjan; Clavien, Pierre-Alain (2020). Exercise Improves Outcomes of Surgery on Fatty Liver in Mice: A Novel Effect Mediated by the AMPK Pathway. Annals of surgery, 271(2), pp. 347-355. Lippincott Williams & Wilkins 10.1097/SLA.0000000000002904
Goossens, Nicolas; Bellentani, Stefano; Cerny, Andreas; Dufour, Jean-François; Jornayvaz, François R; Mertens, Joachim; Moriggia, Alberto; Muellhaupt, Beat; Negro, Francesco; Razavi, Homie; Semela, David; Estes, Chris (2019). Nonalcoholic fatty liver disease burden - Switzerland 2018-2030. Swiss medical weekly, 149, w20152. EMH Media 10.4414/smw.2019.20152
Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V; Montano-Loza, Aldo J; Boursier, Jerome; Mathurin, Philippe; ... (2019). Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet, 394(10215), pp. 2184-2196. Elsevier 10.1016/S0140-6736(19)33041-7
Kim, Richard D; Sarker, Debashis; Meyer, Tim; Yau, Thomas; Macarulla, Teresa; Park, Joong-Won; Choo, Su Pin; Hollebecque, Antoine; Sung, Max W; Lim, Ho-Yeong; Mazzaferro, Vincenzo; Trojan, Joerg; Zhu, Andrew X; Yoon, Jung-Hwan; Sharma, Sunil; Lin, Zhong-Zhe; Chan, Stephen L; Faivre, Sandrine; Feun, Lynn G; Yen, Chia-Jui; ... (2019). First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma. Cancer discovery, 9(12), pp. 1696-1707. American Association for Cancer Research 10.1158/2159-8290.CD-19-0555
Lachenmayer, Anja; Tinguely, Pascale; Maurer, Martin H.; Frehner, Lorenz; Knöpfli, Marina; Peterhans, Matthias; Weber, Stefan; Dufour, Jean-François; Candinas, Daniel; Banz, Vanessa (2019). Stereotactic Image-Guided Microwave Ablation of Hepatocellular Carcinoma using a computer-assisted navigation system. Liver international, 39(10), pp. 1975-1985. Wiley 10.1111/liv.14187
Guarino, Maria; Dufour, Jean-François (2019). Nicotinamide and NAFLD: Is There Nothing New Under the Sun? Metabolites, 9(9) MDPI 10.3390/metabo9090180
Ji, Fanpu; Yeo, Yee Hui; Wei, Mike Tzuhen; Ogawa, Eiichi; Enomoto, Masaru; Lee, Dong Hyun; Iio, Etsuko; Lubel, John; Wang, Wenjun; Wei, Bin; Ide, Tatsuya; Preda, Carmen Monica; Conti, Fabio; Minami, Tatsuya; Bielen, Rob; Sezaki, Hitomi; Barone, Michele; Kolly, Philippe; Chu, Po-Sung; Virlogeux, Victor; ... (2019). Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis. Journal of hepatology, 71(3), pp. 473-485. Elsevier 10.1016/j.jhep.2019.04.017
Wandeler, Gilles; Mauron, Etienne; Atkinson, Andrew; Dufour, Jean-François; Kraus, David; Reiss, Peter; Peters, Lars; Dabis, François; Fehr, Jan; Bernasconi, Enos; van der Valk, Marc; Smit, Colette; Gjærde, Lars K; Rockstroh, Jürgen; Neau, Didier; Bonnet, Fabrice; Rauch, Andri (2019). Incidence of Hepatocellular Carcinoma in HIV/HBV-coinfected Patients on Tenofovir therapy: Relevance for Screening Strategies. Journal of hepatology, 71(2), pp. 274-280. Elsevier 10.1016/j.jhep.2019.03.032
Guarino, Maria; Dufour, Jean-François (2019). Smoking favours hepatocellular carcinoma. Annals of translational medicine, 7(Suppl 3), S99. AME Publishing Company 10.21037/atm.2019.04.90
Piguet, Anne-Christine; Guarino, Maria; Potaczek, Daniel P; Garn, Holger; Dufour, Jean-François (2019). Hepatic gene expression in mouse models of non-alcoholic fatty liver disease after acute exercise. Hepatology research, 49(6), pp. 637-652. Wiley 10.1111/hepr.13323
Wyles, David; Weiland, Ola; Yao, Betty; Weilert, Frank; Dufour, Jean-François; Gordon, Stuart C; Stoehr, Albrecht; Brown, Ashley; Mauss, Stefan; Zhang, Zhenzhen; Pilot-Matias, Tami; Rodrigues, Lino; Mensa, Federico J; Poordad, Fred (2019). Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection. Journal of hepatology, 70(5), pp. 1019-1023. Elsevier 10.1016/j.jhep.2019.01.031
Beldi, Guido; Vuitton, Dominique; Lachenmayer, Anja; Heyd, Bruno; Dufour, Jean-François; Richou, Carine; Candinas, Daniel; Bresson-Hadni, Solange (2019). Is ex vivo liver resection and autotransplantation a valid alternative treatment for end-stage hepatic alveolar echinococcosis in Europe? Journal of hepatology, 70(5), pp. 1030-1031. Elsevier 10.1016/j.jhep.2018.12.011
Lange, Franziska Naomi; Dufour, Jean-François (2019). Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk? Digestive diseases and sciences, 64(4), pp. 903-909. Springer 10.1007/s10620-019-05515-8
Saigi-Morgui, Núria; Quteineh, Lina; Bochud, Pierre-Yves; Crettol, Severine; Kutalik, Zoltán; Mueller, Nicolas J; Binet, Isabelle; Van Delden, Christian; Steiger, Jürg; Mohacsi, Paul; Dufour, Jean-François; Soccal, Paola M; Pascual, Manuel; Eap, Chin B (2019). Genetic and clinic predictors of new onset diabetes mellitus after transplantation. The pharmacogenomics journal, 19(1), pp. 53-64. Nature Publishing Group 10.1038/s41397-017-0001-5
Guarino, Maria; Bovet, Cedric; Dufour, Jean-François (2019). When lifestyles sign. Hepatobiliary surgery and nutrition, 8(1), pp. 69-71. AME Publishing Company 10.21037/hbsn.2018.11.07
Cassano, Marco; Dufour, Jean-François (2019). Inflammation and microbiota fingerprint: Delphi's oracle for NAFLD-related HCC? Hepatology, 69(1), pp. 12-15. Wiley Interscience 10.1002/hep.30267
Quteineh, Lina; Wójtowicz, Agnieszka; Bochud, Pierre-Yves; Crettol, Severine; Vandenberghe, Frederik; Venetz, Jean-Pierre; Manuel, Oriol; Golshayan, Dela; Lehmann, Roger; Mueller, Nicolas J; Binet, Isabelle; van Delden, Christian; Steiger, Jürg; Mohacsi, Paul; Dufour, Jean-François; Soccal, Paola M; Kutalik, Zoltan; Marques-Vidal, Pedro; Vollenweider, Peter; Recher, Mike; ... (2019). Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients. American journal of transplantation, 19(1), pp. 238-246. Wiley-Blackwell 10.1111/ajt.14971
Caversaccio, Nathalie I; Reina Caro, Maria Desiré; Prince Eladnani, Raja; Müller, Martin; Lewis, Clayton S; Bogdanov, Vladimir Y; Dufour, Jean-François; Angelillo, Anne (2018). Alternatively spliced tissue factor levels are elevated in the plasma of patients with chronic liver diseases. European journal of gastroenterology & hepatology, 30(12), pp. 1470-1475. Lippincott Williams & Wilkins 10.1097/MEG.0000000000001236
Beckebaum, Susanne; Herzer, Kerstin; Bauhofer, Artur; Gelson, William; De Simone, Paolo; de Man, Robert; Engelmann, Cornelius; Müllhaupt, Beat; Vionnet, Julien; Salizzoni, Mauro; Volpes, Riccardo; Ercolani, Giorgio; De Carlis, Luciano; Angeli, Paolo; Burra, Patrizia; Dufour, Jean-François; Rossi, Massimo; Cillo, Umberto; Neumann, Ulf; Fischer, Lutz; ... (2018). Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis. Annals of transplantation, 23, pp. 789-801. International Scientific Information 10.12659/AOT.910176
Lim, Ho Yeong; Merle, Philippe; Weiss, Karl Heinz; Yau, Thomas; Ross, Paul; Mazzaferro, Vincenzo; Blanc, Jean-Frédéric; Ma, Yuk Ting; Yen, Chia Jui; Kocsis, Judit; Choo, Su Pin; Sukeepaisarnjaroen, Wattana; Gérolami, René; Dufour, Jean-François; Gane, Edward J; Ryoo, Baek-Yeol; Peck-Radosavljevic, Markus; Dao, Thong; Yeo, Winnie; Lamlertthon, Wisut; ... (2018). Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with -Mutated Hepatocellular Carcinoma. Clinical cancer research, 24(19), pp. 4650-4661. American Association for Cancer Research 10.1158/1078-0432.CCR-17-3588
Rajasekaran, Raviprasadh; Felser, Andrea; Nuoffer, Jean-Marc; Dufour, Jean-François; St-Pierre, Marie (2018). The histidine triad nucleotide-binding protein 2 (HINT-2) positively regulates hepatocellular energy metabolism. FASEB journal, 32(9), pp. 5143-5161. Federation of American Societies for Experimental Biology 10.1096/fj.201701429R
Agarwal, Kosh; Castells, Lluís; Müllhaupt, Beat; Rosenberg, William M C; McNabb, Brian; Arterburn, Sarah; Camus, Gregory; McNally, John; Stamm, Luisa M; Brainard, Diana M; Mani Subramanian, G; Mariño, Zoe; Dufour, Jean-François; Forns, Xavier (2018). Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients. Journal of hepatology, 69(3), pp. 603-607. Elsevier 10.1016/j.jhep.2018.05.039
Miethe, Sarah; Guarino, Maria; Alhamdan, Fahd; Simon, Hans-Uwe; Renz, Harald; Dufour, Jean-François; Potaczek, Daniel P; Garn, Holger (2018). Effects of obesity on asthma: immunometabolic links. Polish archives of internal medicine, 128(7-8), pp. 469-477. Medycyna Praktyczna, Kraków, Poland 10.20452/pamw.4304
Margini, Cristina; Murgia, Giuseppe; Stirnimann, Guido; De Gottardi, Andrea; Semmo, Nasser; Casu, Stefania; Bosch, Jaime; Dufour, Jean-François; Berzigotti, Annalisa (2018). Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease. Hepatology communications, 2(8), pp. 929-940. Wiley 10.1002/hep4.1201
Puoti, Massimo; Foster, Graham R; Wang, Stanley; Mutimer, David; Gane, Edward; Moreno, Christophe; Chang, Ting Tsung; Lee, Samuel S; Marinho, Rui; Dufour, Jean-François; Pol, Stanislas; Hezode, Christophe; Gordon, Stuart C; Strasser, Simone I; Thuluvath, Paul J; Zhang, Zhenzhen; Lovell, Sandra; Pilot-Matias, Tami; Mensa, Federico J (2018). High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis. Journal of hepatology, 69(2), pp. 293-300. Elsevier 10.1016/j.jhep.2018.03.007
Gmür, Andrea; Kolly, Philippe; Knöpfli, Marina Janusheva; Dufour, Jean-François (2018). FACT-Hep increases the accuracy of survival prediction in HCC patients when added to ECOG Performance Status. Liver international, 38(8), pp. 1468-1474. Wiley 10.1111/liv.13711
Bill, Ruben; Montani, Matteo; Blum, Benedikt; Dufour, Jean-François; Escher, Robert; Bühlmann, Michael (2018). Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver. Hepatology, 68(1), pp. 384-386. Wiley Interscience 10.1002/hep.29853
Saran, Uttara; Guarino, Maria; Rodriguez Navarro, Sarai; Simillion, Cedric; Montani, Matteo; Foti, Michelangelo; Humar, Bostjan; St-Pierre, Marie; Dufour, Jean-François (2018). Anti-tumoral effects of exercise on hepatocellular carcinoma growth. Hepatology communications, 2(5), pp. 607-620. Wiley 10.1002/hep4.1159
Keiser, O; Giudici, F; Müllhaupt, B; Junker, C; Dufour, J-F; Moradpour, D; Bruggmann, P; Terziroli, B; Semela, D; Brezzi, M; Bertisch, B; Estill, J; Negro, F; Spoerri, A (2018). Trends in hepatitis C-related mortality in Switzerland. Journal of viral hepatitis, 25(2), pp. 152-160. Blackwell Science 10.1111/jvh.12803
Gerbes, Alexander; Zoulim, Fabien; Tilg, Herbert; Dufour, Jean-François; Bruix, Jordi; Paradis, Valérie; Salem, Riad; Peck-Radosavljevic, Markus; Galle, Peter R; Greten, Tim F; Nault, Jean-Charles; Avila, Matias A (2018). Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut, 67(2), pp. 380-388. BMJ Publishing Group 10.1136/gutjnl-2017-315068
Dufour, Jean-François (2017). In Memoriam: Professor Jürg Reichen (1946–2017). Journal of hepatology, 67(6), p. 1131. Elsevier 10.1016/j.jhep.2017.08.015
Kolly, Philippe; Knöpfli, Marina Janusheva; Dufour, Jean-François (2017). Effect of smoking on survival of patients with hepatocellular carcinoma. Liver international, 37(11), pp. 1682-1687. Wiley 10.1111/liv.13466
Kolly, Philippe; Waidmann, Oliver; Vermehren, Johannes; Moreno, Christophe; Vögeli, Isabelle; Berg, Thomas; Semela, David; Zeuzem, Stefan; Dufour, Jean-François (2017). Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study. Journal of hepatology, 67(4), pp. 876-878. Elsevier 10.1016/j.jhep.2017.07.007
Agarwal, Kosh; Castells, Lluis; Mullhaupt, Beat; M.C. Rosenberg, William; McNabb, Brian; Arterburn, Sarah; Camus, Gregory; McNally, John; Brainard, Diana M.; Subramanian, G. Mani; Gonsalkorala, Enoka; Londoño, Maria; Dufour, Jean-François; Forns, Xavier (October 2017). Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients (Unpublished). In: AASLD. Washington DC. October 2017.
Gmür, Andrea; Kolly, Philippe; Knöpfli, Marina Janusheva; Dufour, Jean-François (October 2017). Quality of life assessment increases the accuracy survival prediction in HCC patient. Hepatology, 66(1), 715A-715A. Wiley Interscience
Puoti, M; Foster, G; Wang, S; Mutimer, D; Gane, E; Moreno, C; Tsung Chang, T; Lee, SS; Marinho, R; Dufour, Jean-François; Pol, S; Hezode, C; Gordon, SC; Strasser, SI; Thuluvath, PJ; Liu, R; Pilot-Matias, T; Mensa, F (14 September 2017). High SVR Rates with 8 and 12 Weeks of Pangenotypic GlecapreviriPibrentasvir: PH2 Integrated Efficacy and Safety Analysis of Genotype 1-6 Patients without Cirrhosis. Swiss medical weekly, 147(Suppl 225), p. 20. EMH Schweizerischer Ärzteverlag
Kachaylo, Ekaterina; Tschuor, Christoph; Calo, Nicolas; Borgeaud, Nathalie; Ungethüm, Udo; Limani, Perparim; Piguet, Anne Christine; Dufour, Jean-François; Foti, Michelangelo; Graf, Rolf; Clavien, Pierre A; Humar, Bostjan (2017). PTEN Down-Regulation Promotes β-Oxidation to Fuel Hypertrophic Liver Growth After Hepatectomy in Mice. Hepatology, 66(3), pp. 908-921. Wiley Interscience 10.1002/hep.29226
von Köckritz, Leona Isabella; Dufour, Jean-François (2017). Management of chronic hepatitis C in 2017. Hämostaseologie, 37(3), pp. 186-195. Schattauer 10.5482/HAMO-16-07-0019
Linecker, Michael; Limani, Perparim; Kambakamba, Patryk; Kron, Philipp; Tschuor, Christoph; Calo, Nicolas; Foti, Michelangelo; Dufour, Jean-François; Graf, Rolf; Humar, Bostjan; Clavien, Pierre-Alain (2017). Omega-3 Fatty Acids Protect Fatty and Lean Mouse Livers After Major Hepatectomy. Annals of surgery, 266(2), pp. 324-332. Lippincott Williams & Wilkins 10.1097/SLA.0000000000001968
Segna, Daniel; Dufour, Jean-François (2017). Other Extrahepatic Manifestations of Hepatitis C Virus Infection (Pulmonary, Idiopathic Thrombocytopenic Purpura, Nondiabetes Endocrine Disorders). Clinics in Liver Disease, 21(3), pp. 607-629. Elsevier 10.1016/j.cld.2017.03.014
Rauh, Christina; Dufour, Jean-François (2017). Nichtalkoholische Fettlebererkrankung (NAFLD). Therapeutische Umschau, 74(3), pp. 87-92. Huber 10.1024/0040-5930/a000890
Dufour, Jean-François (2017). Hepatology Highlights. Hepatology, 65(6), pp. 1783-1784. Wiley Interscience 10.1002/hep.29210
Perazzo, Hugo; Dufour, Jean-François (2017). The therapeutic landscape of non-alcoholic steatohepatitis. Liver international, 37(5), pp. 634-647. Wiley 10.1111/liv.13270
McPherson, Stuart; Hardy, Tim; Dufour, Jean-François; Petta, Salvatore; Romero-Gomez, Manuel; Allison, Mike; Oliveira, Claudia P; Francque, Sven; Van Gaal, Luc; Schattenberg, Jörn M; Tiniakos, Dina; Burt, Alastair; Bugianesi, Elisabetta; Ratziu, Vlad; Day, Christopher P; Anstee, Quentin M (2017). Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis. The American journal of gastroenterology, 112(5), pp. 740-751. Nature Publishing Group 10.1038/ajg.2016.453
Dufour, Jean-François (2017). Hepatology Highlights. Hepatology, 65(5), pp. 1429-1431. Wiley Interscience 10.1002/hep.29149
Dufour, Jean-François (2017). Hepatology Highlights. Hepatology, 65(4), pp. 1081-1083. Wiley Interscience 10.1002/hep.29123
Lévy, Pierre L.; Duponchel, Sarah; Eischeid, Hannah; Molle, Jennifer; Michelet, Maud; Diserens, Gaëlle; Vermathen, Martina; Vermathen, Peter; Dufour, Jean-François; Dienes, Hans-Peter; Steffen, Hans-Michael; Odenthal, Margarete; Zoulim, Fabien; Bartosch, Birke (2017). Hepatitis C virus infection triggers a tumor-like glutamine metabolism. Hepatology, 65(3), pp. 789-803. Wiley Interscience 10.1002/hep.28949
Kolly, Philippe; Dufour, Jean-François (2017). Patients with hepatocellular carcinoma: Your address matters! Journal of hepatology, 66(3), pp. 480-481. Elsevier 10.1016/j.jhep.2016.11.026
Dufour, Jean-François (2017). Hepatology Highlights. Hepatology, 65(3), pp. 761-762. Wiley Interscience 10.1002/hep.29044
Dufour, Jean-François (2017). Hepatology Highlights. Hepatology, 65(2), pp. 399-400. Wiley Interscience 10.1002/hep.28997
Herrmann, Evelyn; Naehrig, Diana; Sassowsky, Manfred; Bigler, Martin; Buijsen, Jeroen; Ciernik, Ilja; Zwahlen, Daniel; Pellanda, Alessandra Franzetti; Meister, Andreas; Brauchli, Peter; Berardi, Simona; Kuettel, Erika; Dufour, Jean-François; Aebersold, Daniel; Swiss Group for Clinical Cancer Research, SAKK (2017). External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26. Radiation oncology, 12(1), p. 12. BioMed Central 10.1186/s13014-016-0745-0
Hari, Andrej; Nair, Harikumar; De Gottardi, Andrea; Baumgartner, Iris; Dufour, Jean-François; Berzigotti, Annalisa (2017). Diagnostic hepatic haemodynamic techniques: safety and radiation exposure. Liver international, 37(1), pp. 148-154. Wiley 10.1111/liv.13215
Dufour, Jean-François (2017). Hepatology Highlights. Hepatology, 65(1), pp. 1-3. Wiley Interscience 10.1002/hep.28935
Tapper, Elliot B; Hughes, Michael S; Buti, Maria; Dufour, Jean-François; Flamm, Steve; Firdoos, Saima; Curry, Michael P; Afdhal, Nezam H (2017). The optimal timing of hepatitis C therapy in transplant eligible patients with Child B and C Cirrhosis: A Cost-Effectiveness Analysis. Transplantation, 101(5), pp. 987-995. Lippincott Williams & Wilkins 10.1097/TP.0000000000001400
Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(6), pp. 1829-1830. Wiley Interscience 10.1002/hep.28867
Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(5), pp. 1395-1397. Wiley Interscience 10.1002/hep.28828
Calo, Nicolas; Ramadori, Pierluigi; Sobolewski, Cyril; Romero, Yannick; Maeder, Christine; Fournier, Margot; Rantakari, Pia; Zhang, Fu-Ping; Poutanen, Matti; Dufour, Jean-François; Humar, Bostjan; Nef, Serge; Foti, Michelangelo (2016). Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption. Gut, 65(11), pp. 1871-1881. BMJ Publishing Group 10.1136/gutjnl-2015-310822
Maan, Raoel; Zaim, Remziye; van der Meer, Adriaan J; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Manns, Michael P; Zeuzem, Stefan; Hansen, Bettina E; Janssen, Harry LA; Veldt, Bart J; de Knegt, Robert J; Uyl-de Groot, Carin A (2016). Real-world medical costs of antiviral therapy among patients with chronic HCV infection and advanced hepatic fibrosis. Journal of gastroenterology and hepatology, 31(11), pp. 1851-1859. Wiley-Blackwell Publishing Asia 10.1111/jgh.13373
Llovet, J; Merle, P; Weiss, KH; Yau, T; Ross, P; Mazzaferro, V; Blanc, JF; Ma, Y; Yen, C; Kocsis, J; Choo, S; Sukeepaisarnjaroen, W; Gerolami, R; Dufour, Jean-François; Gane, E; Ryoo, BY; Peck, M; Dao, T; Yeo, W; Lamlertthon, W; ... (November 2016). Phase II Studies with Refametinib or Refametinib Plus Sorafenib in Patients with Mutant RAS Hepatocellular Carcinoma (HCC). Hepatology, 64(1Suppl), 621A-621A. Wiley Interscience
Munteanu, M.; Tiniakos, D.; Anstee, Q.; Charlotte, F.; Marchesini, G.; Bugianesi, E.; Trauner, M.; Oliveira, C.; Day, C.; Dufour, Jean-François; Bellentani, S.; Ngo, Y.; Traussnig, S.; Bedossa, P.; Ratziu, V.; Poynard, T. (November 2016). Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Hepatology, 64(S1), 585A-585A. Wiley Interscience
Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(4), pp. 1011-1013. Wiley Interscience 10.1002/hep.28764
Giudici, F; Bertisch, B; Negro, F; Stirnimann, G; Müllhaupt, B; Moradpour, D; Cerny, A; Dufour, Jean-François; Keiser, O (2016). Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach. Journal of viral hepatitis, 23(9), pp. 697-707. Blackwell Science 10.1111/jvh.12535
Teufel, Andreas; Itzel, Timo; Erhart, Wiebke; Brosch, Mario; Wang, Xiao Yu; Kim, Yong Ook; von Schönfels, Witigo; Herrmann, Alexander; Brückner, Stefan; Stickel, Felix; Dufour, Jean-François; Chavakis, Triantafyllos; Hellerbrand, Claus; Spang, Rainer; Maass, Thorsten; Becker, Thomas; Schreiber, Stefan; Schafmayer, Clemens; Schuppan, Detlef and Hampe, Jochen (2016). Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients. Gastroenterology, 151(3), pp. 513-525. Elsevier 10.1053/j.gastro.2016.05.051
Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(3), pp. 703-705. Wiley Interscience 10.1002/hep.28725
Teufel, Andreas; Dufour, Jean-François (2016). Two-Step Forward Genetic Screen in Mice Identifies the Ral Pathway as a Central Drug Target in Hepatocellular Carcinoma. Gastroenterology, 151(2), pp. 231-233. Elsevier 10.1053/j.gastro.2016.06.034
Zeuzem, Stefan; Mantry, Parvez; Soriano, Vicente; Buynak, Robert J; Dufour, Jean-François; Pockros, Paul J; Wright, David; Angus, Peter; Buti, Maria; Stern, Jerry O; Kadus, Werner; Vinisko, Richard; Böcher, Wulf; Mensa, Federico J (2016). Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study. European journal of gastroenterology & hepatology, 28(8), pp. 923-926. Lippincott Williams & Wilkins 10.1097/MEG.0000000000000649
Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(2), pp. 325-327. Wiley Interscience 10.1002/hep.28683
Zahnd, Cindy; Salazar-Vizcaya, Luisa; Dufour, Jean-François; Müllhaupt, Beat; Wandeler, Gilles; Kouyos, Roger; Estill, Janne; Bertisch, Barbara; Rauch, Andri; Keiser, Olivia (2016). Modelling the impact of deferring HCV treatment on liver-related complications in HIV coinfected men who have sex with men. Journal of hepatology, 65(1), pp. 26-32. Elsevier 10.1016/j.jhep.2016.02.030
Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(1), pp. 1-3. Wiley Interscience 10.1002/hep.28645
Manns, Michael; Samuel, Didier; Gane, Edward J; Mutimer, David; McCaughan, Geoff; Buti, Maria; Prieto, Martín; Calleja, José Luis; Peck-Radosavljevic, Markus; Müllhaupt, Beat; Agarwal, Kosh; Angus, Peter; Yoshida, Eric M; Colombo, Massimo; Rizzetto, Mario; Dvory-Sobol, Hadas; Denning, Jill; Arterburn, Sarah; Pang, Phillip S; Brainard, Diana; ... (2016). Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial. Lancet infectious diseases, 16(6), pp. 685-697. Elsevier 10.1016/S1473-3099(16)00052-9
Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(6), pp. 1749-1751. Wiley Interscience 10.1002/hep.28605
Koeberle, D; Dufour, Jean-François; Demeter, G; Li, Q; Ribi, K; Samaras, P; Saletti, P; Roth, A D; Horber, D; Bühlmann, Michael; Wagner, A D; Montemurro, M; Lakatos, G; Feilchenfeldt, J; Peck-Radosavljevic, M; Rauch, D; Tschanz, B; Bodoky, G; Swiss Group for Clinical Cancer, SAKK (2016). Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Annals of oncology, 27(5), pp. 856-861. Oxford University Press 10.1093/annonc/mdw054
Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(5), pp. 1405-1407. Wiley Interscience 10.1002/hep.28566
Martin, Juliette; Balmer, Maria Luisa; Rajendran, Saranya; Maurhofer, Olivier; Dufour, Jean-François; St-Pierre Dufour, Marie Vivien (2016). Nutritional stress exacerbates hepatic steatosis induced by deletion of the histidine nucleotide-binding (Hint2) mitochondrial protein. American journal of physiology - gastrointestinal and liver physiology, 310(7), G497-509. American Physiological Society 10.1152/ajpgi.00178.2015
Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(4), pp. 1065-1067. Wiley Interscience 10.1002/hep.28498
Margini, Cristina; Dufour, Jean-François (2016). The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment. Liver international, 36(3), pp. 317-324. Blackwell Munksgaard 10.1111/liv.13031
Foster, G R; Ferenci, P; Asselah, T; Mantry, P; Dufour, Jean-François; Dufour, Jean-François; Bourlière, M; Forton, D; Maevskaya, M; Wright, D; Yoshida, E M; García-Samaniego, J; Oliveira, C; Wright, M; Warner, N; Sha, N; Quinson, A-M; Stern, J O (2016). Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin. Journal of viral hepatitis, 23(3), pp. 227-231. Blackwell Science 10.1111/jvh.12485
Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(3), pp. 679-681. Wiley Interscience 10.1002/hep.28454
Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(2), pp. 351-353. Wiley Interscience 10.1002/hep.28402
Dufour, Jean-François (2016). Time to Abandon NASH? Hepatology, 63(1), pp. 9-10. Wiley Interscience 10.1002/hep.28276
Saran, Uttara; Humar, Bostjan; Kolly, Philippe; Dufour, Jean-François (2016). Hepatocellular carcinoma and lifestyles. Journal of hepatology, 64(1), pp. 203-214. Elsevier 10.1016/j.jhep.2015.08.028
Richani, Mandy; Kolly, Philippe; Knoepfli, Marina; Herrmann, Evelyn; Zweifel, Martin; von Tengg-Kobligk, Hendrik; Candinas, Daniel; Dufour, Jean-François (2016). Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm. Annals of hepatology, 15(1), pp. 82-90. Sociedad Mexicana de Hepatologia
Bechtel-Grosch, Ursina; Béguelin, Charles Antoine; Berezowska, Sabina Anna; Dufour, Jean-François; Takala, Jukka; Schefold, Joerg C. (2016). Fulminant hepatic and multiple organ failure following acute viral tonsillitis: a case report. Journal of medical case reports, 10(7), p. 7. BioMed Central 10.1186/s13256-015-0777-3
Kolly, Philippe; Dufour, Jean-François (2016). Reply to «Lack of evidence of an effect of Direct Acting Antivirals on the recurrence of hepatocellular carcinoma: The ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CIRVIR and CO23 CUPILT cohorts)». Journal of hepatology, 65(6), pp. 1268-1269. Elsevier 10.1016/j.jhep.2016.07.032
Kolly, Philippe; Dufour, Jean-François (2016). Surveillance for Hepatocellular Carcinoma in Patients with NASH. Diagnostics, 6(2), p. 22. MDPI 10.3390/diagnostics6020022
Munteanu, M.; Tiniakos, D.; Anstee, Q.; Charlotte, F.; Marchesini, G.; Bugianesi, E.; Trauner, M.; Romero Gomez, M.; Oliveira, C.; Day, C.; Dufour, Jean-François; Bellentani, S.; Ngo, Y.; Traussnig, S.; Perazzo, H.; Deckmyn, O.; Bedossa, P.; Ratziu, V.; Poynard, T. (2016). Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Alimentary pharmacology & therapeutics, 44(8), pp. 877-889. Wiley-Blackwell 10.1111/apt.13770
Scherer, Antonia; Dufour, Jean-François (2016). Treatment of Non-Alcoholic Fatty Liver Disease. Digestive diseases, 34(Suppl. 1), pp. 27-31. Karger 10.1159/000447278
Buhler, Stéphane; Giostra, Emiliano; Gbame, Corinne; de Rham, Casimir; Mullhaupt, Beat; Dufour, Jean-François; Majno, Pietro; Negro, Francesco; Bochud, Pierre-Yves; Villard, Jean (2015). A significant effect of the KIR ligand HLA-C on fibrosis progression in chronic C hepatitis with or without liver transplantation. Liver international, 36(9), n/a-n/a. Blackwell Munksgaard 10.1111/liv.13057
Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 63(1), pp. 1-3. Wiley Interscience 10.1002/hep.28354
Kolly, Philippe; Reeves, Helen; Sangro, Bruno; Knöpfli, Marina Janusheva; Candinas, Daniel; Dufour, Jean-François (2015). Assessment of the Hong Kong Liver Cancer Staging System in Europe. Liver international, 36(6), pp. 911-917. Blackwell Munksgaard 10.1111/liv.13045
Quteineh, L; Bochud, P-Y; Golshayan, D; Crettol, S; Venetz, J-P; Manuel, O; Kutalik, Z; Treyer, A; Lehmann, R; Mueller, N J; Binet, I; van Delden, C; Steiger, J; Mohacsi, P; Dufour, Jean-François; Soccal, P M; Pascual, M; Semmo, Nasser; Beldi, Guido and Eap, C B (2015). CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation. Pharmacogenomics journal, 17(1), pp. 69-75. Nature Publishing Group 10.1038/tpj.2015.82
van der Meer, Adriaan J; Maan, Raoel; Veldt, Bart J; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Duarte-Rojo, Andres; Manns, Michael P; Zeuzem, Stefan; Peter Hofmann, W; de Knegt, Robert J; Hansen, Bettina E; Janssen, Harry L A (2015). Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis. Journal of gastroenterology and hepatology, 31(6), pp. 1168-1176. Wiley-Blackwell Publishing Asia 10.1111/jgh.13252
Wang, Qixia; Sachse, Karl Philip; Semmo, M; Lokhande, Megha; Montani, Matteo; Dufour, Jean-François; Zoulim, F; Klenerman, Paul; Semmo, Nasser (2015). T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients. Journal of viral hepatitis, 22(12), pp. 1068-1078. Blackwell Science 10.1111/jvh.12428
Bartella, Isabel; Dufour, Jean-François (2015). Clinical Diagnosis and Staging of Intrahepatic Cholangiocarcinoma. Journal of gastrointestinal and liver diseases, 24(4), pp. 481-489. Medical University Press 10.15403/jgld.2014.1121.244.chl
Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(6), pp. 1649-1651. Wiley Interscience 10.1002/hep.28288
Saran, Uttara; Foti, Michelangelo; Dufour, Jean-François (2015). Cellular and molecular effects of the mTOR inhibitor everolimus. Clinical science, 129(10), pp. 895-914. Portland 10.1042/CS20150149
Wang, Hui; El Maadidi, Souhayla; Fischer, Janett; Grabski, Elena; Dickhöfer, Sabine; Klimosch, Sascha; Flannery, Sinead M; Filomena, Angela; Wolz, Olaf-Oliver; Schneiderhan-Marra, Nicole; Löffler, Markus W; Wiese, Manfred; Pichulik, Tica; Müllhaupt, Beat; Semela, David; Dufour, Jean-François; Bochud, Pierre-Yves; Bowie, Andrew G; Kalinke, Ulrich; Berg, Thomas; ... (2015). A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance. Hepatology, 62(5), pp. 1375-1387. Wiley Interscience 10.1002/hep.28105
Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(5), pp. 1331-1333. Wiley Interscience 10.1002/hep.28161
Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(4), pp. 985-987. Wiley Interscience 10.1002/hep.28127
Berzigotti, Annalisa; Saran, Uttara; Dufour, Jean-François (2015). Physical activity and liver diseases. Hepatology, 63(3), pp. 1026-1040. Wiley Interscience 10.1002/hep.28132
Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(3), pp. 663-665. Wiley Interscience 10.1002/hep.27995
Pocha, Christine; Kolly, Philippe; Dufour, Jean-François (2015). Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude. Seminars in liver disease, 35(3), pp. 304-317. Thieme Medical Publishers 10.1055/s-0035-1562949
Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(2), pp. 327-329. Wiley Interscience 10.1002/hep.27933
Piguet, Anne-Christine; Medova, Michaela; Keogh, Adrian; Glück, Astrid Andreina; Aebersold, Daniel; Dufour, Jean-François; Dufour, Jean-François; Zimmer, Yitzhak (2015). Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer. Genes & cancer, 6(7-8), pp. 317-327. Impact Journals
Zhu, Andrew X; Park, Joon Oh; Ryoo, Baek-Yeol; Yen, Chia-Jui; Poon, Ronnie; Pastorelli, Davide; Blanc, Jean-Frederic; Chung, Hyun Cheol; Baron, Ari D; Pfiffer, Tulio Eduardo Flesch; Okusaka, Takuji; Kubackova, Katerina; Trojan, Jorg; Sastre, Javier; Chau, Ian; Chang, Shao-Chun; Abada, Paolo B; Yang, Ling; Schwartz, Jonathan D; Kudo, Masatoshi; ... (2015). Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial. The lancet oncology, 16(7), pp. 859-870. Elsevier 10.1016/S1470-2045(15)00050-9
Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(1), pp. 1-3. Wiley Interscience 10.1002/hep.27898
Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(6), pp. 1773-1775. Wiley Interscience 10.1002/hep.27848
Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(5), pp. 1449-1451. Wiley Interscience 10.1002/hep.27788
Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(4), pp. 1101-1103. Wiley Interscience 10.1002/hep.27749
Toso, Christian; Meeberg, Glenda; Hernandez-Alejandro, Roberto; Dufour, Jean-François; Marotta, Paul; Majno, Pietro; Kneteman, Norman M (2015). Total Tumor Volume and Alpha Fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation. Hepatology, 62(1), pp. 158-165. Wiley Interscience 10.1002/hep.27787
Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(3), pp. 741-743. Wiley Interscience 10.1002/hep.27692
Maan, Raoel; van der Meer, Adriaan J; Hansen, Bettina E; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Manns, Michael P; Zeuzem, Stefan; Janssen, Harry L A; de Knegt, Robert J; Veldt, Bart J (2015). Risk of infections during interferon-based treatment in patients with chronic HCV infection and advanced hepatic fibrosis. Journal of gastroenterology and hepatology, 30(6), pp. 1057-1064. Wiley-Blackwell Publishing Asia 10.1111/jgh.12929
van der Meer, Adriaan J; Hansen, Bettina E; Fattovich, Giovanna; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Duarte-Rojo, Andres; Manns, Michael P; Ieluzzi, Donatella; Zeuzem, Stefan; Hofmann, W Peter; de Knegt, Robert J; Veldt, Bart J; Janssen, Harry L A (2015). Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters. Gut, 64(2), pp. 322-331. BMJ Publishing Group 10.1136/gutjnl-2013-305357
Zeuzem, Stefan; Dufour, Jean-François; Buti, Maria; Soriano, Vicente; Buynak, Robert J; Mantry, Parvez; Taunk, Jawahar; Stern, Jerry O; Vinisko, Richard; Gallivan, John-Paul; Böcher, Wulf; Mensa, Federico J (2015). Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study. Liver international, 35(2), pp. 417-421. Blackwell Munksgaard 10.1111/liv.12693
Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(1), pp. 1-3. Wiley Interscience 10.1002/hep.27602
Piguet, Anne Christine; Saran, Uttara; Simillion, Cedric André Marie; Keller, Irene; Terracciano, Luigi; Reeves, Helen L; Dufour, Jean-François (2015). Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis. Journal of hepatology, 62(6), pp. 1296-1303. Elsevier 10.1016/j.jhep.2015.01.017
Diserens, Gaëlle; Vermathen, Martina; Precht, Maria Christina; Broskey, N T; Boesch, Chris; Amati, F; Dufour, Jean-François; Vermathen, Peter (2015). Separation of small metabolites and lipids in spectra from biopsies by diffusion-weighted HR-MAS NMR: a feasibility study. Analyst, 140(1), pp. 272-279. Royal Society of Chemistry 10.1039/c4an01663g
Ferenci, Peter; Asselah, Tarik; Foster, Graham R; Zeuzem, Stefan; Sarrazin, Christoph; Moreno, Christophe; Ouzan, Denis; Maevskaya, Marina; Calinas, Filipe; Morano, Luis E; Crespo, Javier; Dufour, Jean-François; Bourlière, Marc; Agarwal, Kosh; Forton, Daniel; Schuchmann, Marcus; Zehnter, Elmar; Nishiguchi, Shuhei; Omata, Masao; Kukolj, George; ... (2015). STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection. Journal of hepatology, 62(6), pp. 1246-1255. Elsevier 10.1016/j.jhep.2014.12.024
Zochowska, Monika; Piguet, Anne Christine; Jemielity, Jacek; Kowalska, Joanna; Szolajska, Ewa; Dufour, Jean-François; Chroboczek, Jadwiga (2015). Virus-like particle-mediated intracellular delivery of mRNA cap analog with in vivo activity against hepatocellular carcinoma. Nanomedicine : nanotechnology, biology, and medicine, 11(1), pp. 67-76. Elsevier 10.1016/j.nano.2014.07.009
Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(2), pp. 411-412. Wiley Interscience 10.1002/hep.27652
Wandeler, Gilles; Dufour, Jean-François; Bruggmann, Philip; Rauch, Andri (2015). Hepatitis C: a changing epidemic. Swiss medical weekly, 145, w14093. EMH Schweizerischer Ärzteverlag 10.4414/smw.2015.14093
Hirzel, Cédric; Wandeler, Gilles; Owczarek, Marta; Gorgievski, Meri; Dufour, Jean-François; Semmo, Nasser; Zürcher, Samuel (2015). Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study. BMC infectious diseases, 15(1), p. 483. BioMed Central 10.1186/s12879-015-1234-z
Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(6), pp. 1803-1805. Wiley Interscience 10.1002/hep.27557
van der Meer, Adriaan J; Wedemeyer, Heiner; Feld, Jordan J; Dufour, Jean-François; Zeuzem, Stefan; Hansen, Bettina E; Janssen, Harry L A (2014). Life expectancy in patients with chronic HCV infection and cirrhosis compared with a general population. JAMA : the journal of the American Medical Association, 312(18), pp. 1927-1928. American Medical Association 10.1001/jama.2014.12627
Beyoglu, Diren; Krausz, K. W.; Martin, Juliette; Maurhofer, Olivier; Dorow, J.; Ceglarek, U.; Gonzalez, F. J.; Dufour, Jean-François; Idle, Jeffrey (2014). Disruption of tumor suppressor gene Hint1 leads to remodeling of the lipid metabolic phenotype of mouse liver. Journal of lipid research, 55(11), pp. 2309-2319. American Society for Biochemistry and Molecular Biology ASBMB 10.1194/jlr.M050682
Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(5), pp. 1455-1457. Wiley Interscience 10.1002/hep.27428
Dufour, Jean-François (October 2014). Impact of Lifestyle on NAFLD (Unpublished). In: UEG Annual Meeting. Wien. October 2014.
Dufour, Jean-François (October 2014). Hepatocellular carcinoma: what is new in 2014 (Unpublished). In: UEG Annual Meeting. Wien. October 2014.
Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(4), pp. 1119-20. Wiley Interscience 10.1002/hep.27384
Rüeger, S; Bochud, P-Y; Dufour, Jean-François; Müllhaupt, B; Semela, D; Heim, M H; Moradpour, D; Cerny, A; Malinverni, R; Booth, D R; Suppiah, V; George, J; Argiro, L; Halfon, P; Bourlière, M; Talal, A H; Jacobson, I M; Patin, E; Nalpas, B; Poynard, T; ... (2014). Impact of common risk factors of fibrosis progression in chronic hepatitis C. Gut, 64(10), pp. 1605-1615. BMJ Publishing Group 10.1136/gutjnl-2014-306997
Maan, Raoel; van der Meer, Adriaan J; Hansen, Bettina E; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Zangneh, Hooman F; Lammert, Frank; Manns, Michael P; Zeuzem, Stefan; Janssen, Harry L A; de Knegt, Robert J; Veldt, Bart J (2014). Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis. Journal of hepatology, 61(3), pp. 482-491. Elsevier 10.1016/j.jhep.2014.04.021
Dufour, Jean-François (September 2014). TACE: Who, When, How and How to evaluate? (Unpublished). In: HCC Day. Lausanne. September 2014.
Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(3), pp. 773-775. Wiley Interscience 10.1002/hep.27327
Dufour, Jean-François (August 2014). Directly acting antivirals for the treatment of hepatitis C: key messages from phase III tri-als’. (Unpublished). In: Swiss Society for Infectious Diseases. Aarau. August 2014.
Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(2), pp. 445-447. Wiley Interscience 10.1002/hep.27270
Liu, Y-L; Patman, G L; Leathart, J B S; Piguet, Anne Christine; Burt, A D; Dufour, Jean-François; Day, C P; Daly, A K; Reeves, H L; Anstee, Q M (2014). Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. Journal of hepatology, 61(1), pp. 75-81. Elsevier 10.1016/j.jhep.2014.02.030
Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(1), pp. 1-3. Wiley Interscience 10.1002/hep.27226
Dufour, Jean-François (June 2014). The ABC of viral Hepatitis (Unpublished). In: UEG Summer school. Prague. June 2014.
Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(6), pp. 2059-2061. Wiley Interscience 10.1002/hep.27166
Dufour, Jean-François (2014). Hepatocellular carcinoma: sorafenib: for once age is not an issue. Nature reviews - gastroenterology & hepatology, 11(5), pp. 273-274. Nature Publishing Group 10.1038/nrgastro.2014.48
Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(5), pp. 1657-1659. Wiley Interscience 10.1002/hep.27130
Frei, Pascal; Leucht, Anna-Kathrin; Held, Ulrike; Kofmehl, Reto; Manser, Christine N.; Schmitt, Johannes; Mertens, Joachim; Rau, Monika; Baur, Katharina; Gerlach, Tilman; Negro, Francesco; Heim, Markus; Moradpour, Darius; Cerny, Andreas; Dufour, Jean-François; Müllhaupt, Beat; Geier, Andreas (2014). Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients. Liver international, 34(4), pp. 551-557. Blackwell Munksgaard 10.1111/liv.12279
Patsenker, Eleanora; Sachse, Philip; Mattsson, Johan; Lanz, Christian; Schneider, Vreni; Brenneisen, Rudolf Max; De Gottardi, Andrea; Dufour, Jean-François; Stickel, Felix; Semmo, Nasser (April 2014). Endocannabinoids Suppress Cytokine Secretion in HCV Infection (Unpublished). In: EASL International Liver Congress 2014. London, UK. 09.-13.04.2014.
De Gottardi, Andrea; Banz Wüthrich, Vanessa; Storni, Federico; Stirnimann, Guido; Semmo, Nasser; Engelmann, C; Piguet, Anne Christine; Whittaker, S; Lammert, F; Berg, T; Zeuzern, S; Cordoba, J; Dufour, Jean-François (April 2014). Safety and Efficacy of an Automated Low Flow Ascites (alfa) Pump in Cirrhotic Patients with Refractory Ascites. In: EASL International Liver Congress 2014. London, UK. 09.-13.04.2014.
Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(4), pp. 1217-1219. Wiley Interscience 10.1002/hep.27075
Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(3), pp. 743-745. Wiley Interscience 10.1002/hep.27021
Dufour, Jean-François (February 2014). HCC: combination local-systemic therapies (Unpublished). In: EASL Monothematic Conference. Geneva. February 2014.
Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(2), pp. 357-359. Wiley Interscience 10.1002/hep.26973
Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(1), pp. 1-3. Wiley Interscience 10.1002/hep.26935
Al Hasani, Farah; Knoepfli, Marina; Gemperli, Armin; Kollár, Attila; Banz, Vanessa; Kettenbach, Joachim; Jüni, Peter; Dufour, Jean-François (2014). Factors affecting screening for hepatocellular carcinoma. Annals of hepatology, 13(2), pp. 204-210. Sociedad Mexicana de Hepatologia
Piguet, Anne Christine; Majumder, Syamantak; Maheshwari, Uma; Manjunathan, Reji; Saran, Uttara; Chatterjee, Suvro; Dufour, Jean-François (2014). Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo , while demonstrating anti-angiogenic activities. Clinical science, 126(11), pp. 775-784. Portland 10.1042/CS20130081
Perazzo, Hugo; Poynard, Thierry; Dufour, Jean-François; Dufour, Jean-François (2014). The Interactions of Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases. Clinics in Liver Disease, 18(1), pp. 233-248. Elsevier 10.1016/j.cld.2013.09.014
Terczyńska-Dyla, Ewa; Bibert, Stephanie; Duong, Francois H. T.; Krol, Ilona; Jørgensen, Sanne; Collinet, Emilie; Kutalik, Zoltán; Aubert, Vincent; Cerny, Andreas; Kaiser, Laurent; Malinverni, Raffaele; Mangia, Alessandra; Moradpour, Darius; Müllhaupt, Beat; Negro, Francesco; Santoro, Rosanna; Semela, David; Semmo, Nasser; Rubbia-Brandt, Laura; Martinetti, Gladys; ... (2014). Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nature communications, 5, p. 5699. Nature Publishing Group 10.1038/ncomms6699
Liu, Yang-Lin; Reeves, Helen L; Burt, Alastair D; Tiniakos, Dina; McPherson, Stuart; Leathart, Julian B S; Allison, Michael E D; Alexander, Graeme J; Piguet, Anne Christine; Anty, Rodolphe; Donaldson, Peter; Aithal, Guruprasad P; Francque, Sven; Van Gaal, Luc; Clement, Karine; Ratziu, Vlad; Dufour, Jean-François; Day, Christopher P; Daly, Ann K and Anstee, Quentin M (2014). TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nature communications, 5(4309), p. 4309. Nature Publishing Group 10.1038/ncomms5309
Dufour, Jean-François (2014). Liver Cancer in Metabolic Diseases (Unpublished). In: UEG Single Topic Conference. Birmingham.
Erös de Bethlenfalva - Hora, Caroline; Mertens, Joachim C.; Piguet, Anne Christine; Kettenbach, Joachim; Schmitt, Johannes; Terracciano, Luigi; Weimann, Rosemarie; Dufour, Jean-François; Geier, Andreas (2014). Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma. Clinical science, 126(3), pp. 243-252. Portland 10.1042/CS20130089
Dufour, Jean-François (2013). Hepatology Highlights. Hepatology, 58(6), pp. 1869-1870. Wiley Interscience 10.1002/hep.26780
Ndiaye, Dieynaba; Collado-Hilly, Mauricette; Martin, Juliette; Prigent, Sylvie; Dufour, Jean-François; Combettes, Laurent; Dupont, Geneviève (2013). Characterization of the Effect of the Mitochondrial Protein Hint2 on Intracellular Ca2+ dynamics. Biophysical journal, 105(5), pp. 1268-1275. Biophysical Society 10.1016/j.bpj.2013.06.048
Beyoglu, Diren; Imbeaud, Sandrine; Maurhofer, Olivier; Bioulac-Sage, Paulette; Zucman-Rossi, Jessica; Dufour, Jean-François; Idle, Jeffrey R. (2013). Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification. Hepatology, 58(1), pp. 229-238. Wiley Interscience 10.1002/hep.26350
Bibert, Stéphanie; Roger, Thierry; Calandra, Thierry; Bochud, Murielle; Cerny, Andreas; Semmo, Nasser; Duong, François H. T.; Gerlach, Tilman; Malinverni, Raffaele; Moradpour, Darius; Negro, Francesco; Müllhaupt, Beat; Bochud, Pierre-Yves; Swiss Hepatitis C Cohort Study, the; Dufour, Jean-François (2013). IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction. Journal of experimental medicine, 210(6), pp. 1109-1116. Rockefeller University Press 10.1084/jem.20130012
Beyoglu, Diren; Dufour, Jean-François; Idle, Jeffrey (February 2013). Lipid metabolomics in hepatocellular carcinoma (Unpublished). In: EASL Monothematic Conference. Luxembourg. Februar 2013.
Rau, Monika; Stickel, Felix; Russmann, Stefan; Manser, Christine N; Becker, Philip P; Weisskopf, Michael; Schmitt, Johannes; Dill, Michael T; Dufour, Jean-François; Moradpour, Darius; Semela, David; Müllhaupt, Beat; Geier, Andreas; Swiss Hepatitis C Cohort Study Group (SCCS), (2013). Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection. Journal of hepatology, 58(4), pp. 669-75. Amsterdam: Elsevier 10.1016/j.jhep.2012.11.027
Leichtle, Alexander Benedikt; Dufour, Jean-François; Fiedler, Martin (2013). Potentials and pitfalls of clinical peptidomics and metabolomics. Swiss medical weekly, 143, w13801. EMH Schweizerischer Ärzteverlag 10.4414/smw.2013.13801
Röther, Mareike; Dufour, Jean-François; Schnüriger, Beat (2013). An Uncommon Cause of a Focal Liver Lesion. Gastroenterology, 144(3), pp. 510-659. Elsevier 10.1053/j.gastro.2012.10.017
van der Meer, A. J.; Veldt, B. J.; Feld, J. J.; Wedemeyer, H.; Dufour, Jean-François; Lammert, F.; Duarte-Rojo, A.; Manns, M. P.; Zeuzem, S.; Hofmann, W. P.; de Knegt, R. J.; Hansen, B. E.; Janssen, H. L. A. (2013). The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection. Journal of viral hepatitis, 21(8), pp. 568-577. Blackwell Science 10.1111/jvh.12185
Tonko, Sebastian; Dufour, Jean-François (2013). Hepatologische Scores. Therapeutische Umschau, 70(10), pp. 577-579. Huber 10.1024/0040-5930/a000450
Lange, Christian M.; Miki, Daiki; Ochi, Hidenori; Nischalke, Hans-Dieter; Bojunga, Jörg; Bibert, Stéphanie; Morikawa, Kenichi; Gouttenoire, Jérôme; Cerny, Andreas; Dufour, Jean-François; Gorgievski, Meri; Heim, Markus H.; Malinverni, Raffaele; Müllhaupt, Beat; Negro, Francesco; Semela, David; Kutalik, Zoltan; Müller, Tobias; Spengler, Ulrich; Berg, Thomas; ... (2013). Genetic Analyses Reveal a Role for Vitamin D Insufficiency in HCV-Associated Hepatocellular Carcinoma Development. PLoS ONE, 8(5), e64053. Public Library of Science 10.1371/journal.pone.0064053
Dufour, Jean-François; Bargellini, I.; De Maria, N.; De Simone, P.; Goulis, I.; Marinho, R. T. (2013). Intermediate hepatocellular carcinoma: current treatments and future perspectives. Annals of oncology, 24(Suppl. 2), ii24-ii29. Oxford University Press 10.1093/annonc/mdt054
Lange, Christian M.; Bibert, Stéphanie; Dufour, Jean-François; Cellerai, Cristina; Cerny, Andreas; Heim, Markus H.; Kaiser, Laurent; Malinverni, Raffaele; Müllhaupt, Beat; Negro, Francesco; Semela, David; Moradpour, Darius; Kutalik, Zoltán; Bochud, Pierre-Yves (2013). Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. Journal of hepatology, 59(3), pp. 504-509. Elsevier 10.1016/j.jhep.2013.04.032
Thattil, Raphael; Dufour, Jean-François (2013). Hepatocellular carcinoma in a non-cirrhotic patient with Wilson's disease. World journal of gastroenterology, 19(13), pp. 2110-2113. WJG Press 10.3748/wjg.v19.i13.2110
Dufour, Jean-François (2013). Modern Hepatomancy. Gastroenterology, 144(5), pp. 876-878. Elsevier 10.1053/j.gastro.2013.03.015
Majumder, Syamantak; Piguet, Anne Christine; Dufour, Jean-François; Chatterjee, Suvro (2013). Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis. European journal of pharmacology, 705(1-3), pp. 86-95. Elsevier 10.1016/j.ejphar.2013.02.026
Dufour, Jean-François (2013). C-reactive protein, a prognostic marker in hepatocellular carcinoma. Hepatology, 57(6), pp. 2103-2105. Wiley Interscience 10.1002/hep.26250
Bochud, Pierre-Yves; Bibert, Stéphanie; Kutalik, Zoltán; Patin, Etienne; Guergnon, Julien; Nalpas, Bertrand; Goossens, Nicolas; Kuske, Lorenz; Müllhaupt, Beat; Gerlach, Tillman; Heim, Markus H; Moradpour, Darius; Cerny, Andreas; Malinverni, Raffaele; Regenass, Stephan; Dollenmaier, Guenter; Hirsch, Hans; Martinetti, Gladys; Gorgiewski, Meri; Bourlière, Marc; ... (2012). IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes. Hepatology, 55(2), pp. 384-94. Hoboken, N.J.: Wiley Interscience 10.1002/hep.24678
St-Pierre, Marie V; Dufour, Jean-François (2012). Biomarkers for Hepatocellular Apoptosis in the Management of Liver Diseases. Current pharmaceutical biotechnology, 13(11), pp. 2221-7. Hilversum: Bentham Science Publishers
Martin, Juliette; Maurhofer, Olivier; Bellance, Nadège; Benard, Giovanni; Graber, Franziska; Hahn, Dagmar Karen; Galinier, Anne; Hora, Caroline; Gupta, Anirudh; Ferrand, Gisèle; Hoppeler, Hans; Rossignol, Rodrigue; Dufour, Jean-François; St-Pierre, Marie V (2012). Disruption of the histidine triad nucleotide-binding hint2 gene in mice affects glycemic control and mitochondrial function. Hepatology, 57(5), pp. 2037-2048. Hoboken, N.J.: Wiley Interscience 10.1002/hep.26060
Bürgi, Anne-Catherine; Dufour, Jean-François (2012). [Treatment of nonalcoholic steatohepatitis]. Revue du praticien, 62(10), pp. 1425-7. Neuilly-sur-Seine: Global Média Santé
Bolondi, Luigi; Burroughs, Andrew; Dufour, Jean-François; Galle, Peter R; Mazzaferro, Vincenzo; Piscaglia, Fabio; Raoul, Jean Luc; Sangro, Bruno (2012). Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions. Seminars in liver disease, 32(4), pp. 348-59. New York, N.Y.: Thieme Medical Publishers 10.1055/s-0032-1329906
van der Meer, Adriaan J; Veldt, Bart J; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Duarte-Rojo, Andres; Heathcote, E Jenny; Manns, Michael P; Kuske, Lorenz; Zeuzem, Stefan; Hofmann, W Peter; de Knegt, Robert J; Hansen, Bettina E; Janssen, Harry L A (2012). Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA - the journal of the American Medical Association, 308(24), pp. 2584-93. Chicago, Ill.: American Medical Association 10.1001/jama.2012.144878
Liechti, Fabia; Dufour, Jean-François (2012). Treatment of NASH with ursodeoxycholic acid: cons. Clinics and research in hepatology and gastroenterology, 36 Suppl 1, S46-52. Paris: Elsevier Masson 10.1016/S2210-7401(12)70021-9
Kuske, Lorenz; Mensen, Armand; Müllhaupt, Beat; Negro, Francesco; Semela, David; Moradpour, Darius; Malé, Pierre Jean; Heim, Markus H; Malinverni, Raffaele; Cerny, Andreas; Dufour, Jean-François; Swiss Hepatitis C Cohort Study, (2012). Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma. Swiss medical weekly, 142, w13651. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2012.13651
Patin, Etienne; Kutalik, Zoltán; Guergnon, Julien; Bibert, Stéphanie; Nalpas, Bertrand; Jouanguy, Emmanuelle; Munteanu, Mona; Bousquet, Laurence; Argiro, Laurent; Halfon, Philippe; Boland, Anne; Müllhaupt, Beat; Semela, David; Dufour, Jean-François; Heim, Markus H; Moradpour, Darius; Cerny, Andreas; Malinverni, Raffaele; Hirsch, Hans; Martinetti, Gladys; ... (2012). Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection. Gastroenterology, 143(5), 1244-52.e1-12. Philadelphia, Pa.: Elsevier 10.1053/j.gastro.2012.07.097
Lange, Christian M; Bibert, Stephanie; Kutalik, Zoltan; Burgisser, Philippe; Cerny, Andreas; Dufour, Jean-François; Geier, Andreas; Gerlach, Tilman J; Heim, Markus H; Malinverni, Raffaele; Negro, Francesco; Regenass, Stephan; Badenhoop, Klaus; Bojunga, Jörg; Sarrazin, Christoph; Zeuzem, Stefan; Müller, Tobias; Berg, Thomas; Bochud, Pierre-Yves; Moradpour, Darius; ... (2012). A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. PLoS ONE, 7(7), e40159. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0040159
Sieghart, Wolfgang; Pinter, Matthias; Dauser, Bernhard; Rohr-Udilova, Natalya; Piguet, Anne-Christine; Prager, Gerald; Hayden, Hubert; Dienes, Hans-Peter; Dufour, Jean-François; Peck-Radosavljevic, Markus (2012). Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma. Journal of hepatology, 57(3), pp. 592-9. Amsterdam: Elsevier 10.1016/j.jhep.2012.04.034
Dufour, Jean-François (2012). Anti-angiogenic therapy for HCC. Minerva medica, 58(1), pp. 81-6. Torino: Minerva Medica
Dufour, Jean-François (2012). TACE with or without systemic therapy? Journal of hepatology, 56(6), pp. 1224-5. Amsterdam: Elsevier 10.1016/j.jhep.2012.01.006
Dufour, Jean-François; Le Gallou, Thomas; Cordier, Jean-François; Aumaître, Olivier; Pinède, Laurent; Aslangul, Elisabeth; Pagnoux, Christian; Marie, Isabelle; Puéchal, Xavier; Decaux, Olivier; Dubois, Alain; Agard, Christian; Mahr, Alfred; Comoz, François; Boutemy, Jonathan; Broussolle, Christiane; Guillevin, Loïc; Sève, Pascal; Bienvenu, Boris; French Center-East Internists Group, ; ... (2012). Urogenital manifestations in Wegener granulomatosis: a study of 11 cases and review of the literature. Medicine, 91(2), pp. 67-74. Baltimore, Md.: Lippincott Williams & Wilkins 10.1097/MD.0b013e318239add6
Lange, Christian M; Kutalik, Zoltan; Morikawa, Kenichi; Bibert, Stéphanie; Cerny, Andreas; Dollenmaier, Günter; Dufour, Jean-François; Gerlach, Tilman J; Heim, Markus H; Malinverni, Raffaele; Müllhaupt, Beat; Negro, Francesco; Moradpour, Darius; Bochud, Pierre-Yves; Swiss Hepatitis C Cohort Study Group, (2012). Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy. Hepatology, 55(4), pp. 1038-47. Hoboken, N.J.: Wiley Interscience 10.1002/hep.24787
Girardin, F; Daali, Y; Gex-Fabry, M; Rebsamen, M; Roux-Lombard, P; Cerny, A; Bihl, F; Binek, J; Moradpour, D; Negro, F; Desmeules, J; Swiss Hepatitis C Cohort Study Group, (2012). Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection. Journal of viral hepatitis, 19(8), pp. 568-73. Oxford: Blackwell Science 10.1111/j.1365-2893.2011.01578.x
EASL, (2012). EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. European journal of cancer, 2012(48 (5)), pp. 599-641. Amsterdam: Elsevier 10.1016/j.ejca.2011.12.021
Baur, Katharina; Mertens, Joachim C; Schmitt, Johannes; Iwata, Rika; Stieger, Bruno; Frei, Pascal; Seifert, Burkhardt; Bischoff Ferrari, Heike A; von Eckardstein, Arnold; Müllhaupt, Beat; Geier, Andreas; Swiss Hepatitis C Cohort Study Group, (2012). The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients. Antiviral therapy, 17(3), pp. 541-7. London: International Medical Press 10.3851/IMP2018
Piguet, Anne-Christine; Saar, Bettina; Hlushchuk, Ruslan; St-Pierre, Marie V; McSheehy, Paul M J; Radojevic, Vesna; Afthinos, Maresa; Terracciano, Luigi; Djonov, Valentin; Dufour, Jean-François (2011). Everolimus augments the effects of sorafenib in a syngeneic orthotopic model of hepatocellular carcinoma. Molecular cancer therapeutics, 10(6), pp. 1007-17. Philadelphia, Pa.: American Association for Cancer Research AACR 10.1158/1535-7163.MCT-10-0666
Patterson, Andrew D; Maurhofer, Olivier; Beyoglu, Diren; Lanz, Christian; Krausz, Kristopher W; Pabst, Thomas; Gonzalez, Frank J; Dufour, Jean-François; Idle, Jeffrey R (2011). Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer research, 71(21), pp. 6590-600. Birmingham, Ala.: American Association for Cancer Research AACR 10.1158/0008-5472.CAN-11-0885
Morell, Bernhard; Dufour, Jean-François (2011). [Liver transplantation - when and for whom it should be performed]. Therapeutische Umschau, 68(12), pp. 707-13. Bern: Huber 10.1024/0040-5930/a000234
Yao, Francis Y; Breitenstein, Stefan; Broelsch, Christoph E; Dufour, Jean-François; Sherman, Morris (2011). Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma? Liver transplantation, 17 Suppl 2, S109-S116. Hoboken, N.J.: Wiley 10.1002/lt.22335
Balmer, Maria Luisa; Dufour, Jean-François (2011). [Non-alcoholic steatohepatitis - from NAFLD to MAFLD]. Therapeutische Umschau, 68(4), pp. 183-8. Bern: Huber 10.1024/0040-5930/a000148
Martin, Juliette; St-Pierre, Marie V; Dufour, Jean-François (2011). Hit proteins, mitochondria and cancer. Biochimica et biophysica acta - bioenergetics, 1807(6), pp. 626-32. Amsterdam: Elsevier 10.1016/j.bbabio.2011.02.001
Hora, Caroline; Romanque, Pamela; Dufour, Jean-François (2011). Effect of sorafenib on murine liver regeneration. Hepatology, 53(2), pp. 577-86. Hoboken, N.J.: Wiley Interscience 10.1002/hep.24037
Cai, Tao; Dufour, Jean-François; Muellhaupt, Beat; Gerlach, Tilman; Heim, Markus; Moradpour, Darius; Cerny, Andreas; Malinverni, Raffaele; Kaddai, Vincent; Bochud, Murielle; Negro, Francesco; Bochud, Pierre-Yves; Swiss Hepatitis C Cohort Study Group, (2011). Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis. Journal of hepatology, 55(3), pp. 529-35. Amsterdam: Elsevier 10.1016/j.jhep.2010.12.020
Piguet, Anne-Christine; Dufour, Jean-François (2011). PI(3)K/PTEN/AKT pathway. Journal of hepatology, 54(6), pp. 1317-9. Amsterdam: Elsevier 10.1016/j.jhep.2010.12.013
Haedrich, Marion; Dufour, Jean-François (2011). UDCA for NASH: end of the story? Journal of hepatology, 54(5), pp. 856-8. Amsterdam: Elsevier 10.1016/j.jhep.2010.10.009
Martin, Juliette; Romanque, Pamela; Maurhofer, Olivier; Schmitter, Karin; Hora, Caroline; Ferrand, Gisèle; Dufour, Jean-François (2011). Ablation of the tumor suppressor histidine triad nucleotide binding protein 1 is protective against hepatic ischemia/reperfusion injury. Hepatology, 53(1), pp. 243-52. Hoboken, N.J.: Wiley Interscience 10.1002/hep.23978
Martin, Juliette; Dufour, Jean-François (2011). Abnormal nitrosothiol metabolism in hepatocellular carcinoma. Journal of hepatology, 54(3), pp. 579-80. Amsterdam: Elsevier 10.1016/j.jhep.2010.10.011
Van der Meer, AJ; Veldt, BJ; Feld, JJ; Wedemeyer, H; Dufour, Jean-François; Lammert, F; Duarte-Rojo, A; Heathcote, EJ; Manns, MP; Kuske, L; Zeuzem, S; Hofmann, WP; de Knegt, RJ; Hansen, BE; Janssen, HL (2011). Sustained Virological Response Improves Overall Survival in Chronic Hepatitis C Patients with Advanced Fibrosis. Hepatology, 54(1), 441A-441A. Hoboken, N.J.: Wiley Interscience
Van der Meer, AJ; Veldt, BJ; Feld, JJ; Wedemeyer, H; Dufour, Jean-François; Lammert, F; Duarte-Rojo, A; Heathcote, EJ; Manns, MP; Kuske, L; Zeuzem, S; Hofmann, WP; de Knegt, RJ; Hansen, BE; Janssen, HL (2011). Improved Platelet Count and Smaller Spleen Size Long After Sustained Virological Response in Chronic Hepatitis C Patients With Advance Fibrosis. Hepatology, 54(1), 820A-820A. Hoboken, N.J.: Wiley Interscience
Frei, P; Leucht, AK; Held, U; Kofmehl, R; Schmitt, J; Rau, M; Gerlach, T; Negro, F; Heim, MH; Moradpour, D; Cerny, A; Dufour, Jean-François; Mullhaupt, B; Geier, A (2011). Age Above 60 Years Is Not a Negative Predictive Factor For Combined Antiviral Therapy With Pegylated Interferon Alpha and Ribavirin in Hepatitis C Patients. Hepatology, 54(1), 826A-826A. Hoboken, N.J.: Wiley Interscience
Lange, CM; Bibert, S; Kutalik, Z; Morikawa, K; Cerny, A; Dufour, Jean-François; Gerlach, TJ; Heim, MH; Malinverni, R; Muellhaupt, B; Negro, F; Badenhoop, K; Sarrazin, C; Berg, T; Gouttenoire, J; Bochud, PY; Moradpour, D (2011). Swiss Hepatitis C Cohort Study. A Large Scale Genetic Validation Study Coupled With In-Vitro Analysis Reveal a Role of Vitamin D-Signaling in the Pathogenesis and Treatment of Chronic Hepatitis C. Hepatology, 54(1), p. 537. Hoboken, N.J.: Wiley Interscience 10.1016/S0168-8278(11)61359-7
Bochud, PY; Bibert, S; Kutalik, Z; Patin, E; Guergnon, J; Nalpas, B; Goossens, N; Kuske, L; Müllhaup, B; Gerlach, T; Heim, MH; Moradpour, D; Cerny, A; Malinverni, R; Regenass, S; Dollenmaier, G; Hirsch, H; Martinetti, G; Gorgiewski, M; Boulière, M; ... (2011). Swiss Hepatitis C Cohort Study Grp. IL28B Polymorphisms Linked to Poor Response To Treatment are Associated with Low Necroinflammatory Activity and Slow Fibrosis Progression in HCV Genotype Non-1-Infected patientsBern. Hepatology, 54(1), p. 539. Hoboken, N.J.: Wiley Interscience 10.1016/S0168-8278(11)61363-9
Hora, C; Mertens, J; Saar, B; Kettenbach, J; Ledermann, M; C Piguet, A; Mertens, S; Schmitt, J; F Dufour, J; Geier, A (2011). Effects of Radiofrequency Ablation (RFA) In Combination With Sorafenib In a 2-Tumor Rat Model of Hepatocellular Carcinoma. Hepatology, 54(1), p. 89. Hoboken, N.J.: Wiley Interscience 10.1016/S0168-8278(11)60213-4
Lange, CM; Kutalik, Z; Morikawa, K; Bibert, S; Cerny, A; Dollenmaier, G; Dufour, Jean-François; Gerlach, TJ; Heim, MH; Malinverni, R; Müllhaupt, B; Negro, F; Moradpour, D; Bochud, PY (2011). the Swiss Hepatitis C Cohort Study Group. Hepatology Hoboken, N.J.: Wiley Interscience
Dufour, Jean-François (2010). Treat the bones and get less rejection! Liver international, 30(3), pp. 337-8. Oxford: Blackwell Munksgaard 10.1111/j.1478-3231.2009.02189.x
Dufour, Jean-François; Johnson, Philip (2010). Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference. Journal of hepatology, 52(2), pp. 296-304. Amsterdam: Elsevier
Piguet, Anne-Christine; Stroka, Deborah; Zimmermann, Arthur; Dufour, Jean-François (2010). Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. Clinical science, 118(6), pp. 401-10. London: Portland 10.1042/CS20090313
Dufour, Jean-François; Hoppe, Hanno; Heim, Markus H; Helbling, Beat; Maurhofer, Olivier; Szucs-Farkas, Zsolt; Kickuth, Ralph; Borner, Markus; Candinas, Daniel; Saar, Bettina (2010). Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study. Oncologist, 15(11), pp. 1198-204. Miamisburg, Ohio: AlphaMed Press 10.1634/theoncologist.2010-0180
Dufour, Jean-François (2010). Vitamin E for nonalcoholic steatohepatitis: ready for prime time? Hepatology, 52(2), pp. 789-792. Hoboken, N.J.: Wiley Interscience 10.1002/hep.23817
Rauch, Andri; Kutalik, Zoltán; Descombes, Patrick; Cai, Tao; Di Iulio, Julia; Mueller, Tobias; Bochud, Murielle; Battegay, Manuel; Bernasconi, Enos; Borovicka, Jan; Colombo, Sara; Cerny, Andreas; Dufour, Jean-François; Furrer, Hansjakob; Günthard, Huldrych F; Heim, Markus; Hirschel, Bernard; Malinverni, Raffaele; Moradpour, Darius; Müllhaupt, Beat; ... (2010). Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology, 138(4), 1338-45, 1345.e1-7. Philadelphia, Pa.: Elsevier 10.1053/j.gastro.2009.12.056
Balmer, ML; F.Dufour, J. (2010). Molecular mechanisms of liver cancer metastasis. Bantham Publishers
Balmer, ML; Joneli, J; Schoepfer, A; Stickel, F; Thormann, W; Dufour, Jean-François (2010). Significance of serum adiponection levels in patients with chronic liver disease. Clinical science, 119(10), pp. 431-36. London: Portland 10.1042/CS20100008
Chtiou, H; Mauerhofer, O; Günther, B; Dufour, Jean-François (2010). Macro-AST in an asymptomatic young patient. Annals of hepatology, 9(1), pp. 93-5. México City: Sociedad Mexicana de Hepatologia
Overbeck, K; Dufour, Jean-François; Müllhaupt, B; Helbling, B; Borovicka, J; Malinverni, R; Heim, M; Moradpur, D; Cerny, A; Rickenbach, M; Negro, F (2010). Impact of international consensus guidelines on atniviral therapy of chronic hepatitis C patients in Switzerland. Swiss medical weekly Muttenz: EMH Schweizerischer Ärzteverlag
Hora, C; Dufour, Jean-François (2010). Primary Hepatocellular Carcinoma 5. Berlin-Heidelberg: Springer 10.1007/978-1-4419-7107-4_56
Balmer, ML; Dufour, Jean-François (2010). Biology of Hepatocellular Carcinoma. New York: Humana Press 10.1007/978-1-60327-522-4_2
Sendensy, A; Dufour, Jean-François (2010). Physiology of Liver Functions. Berlin-Heidelberg: Springer
Seitz, M; Reichenbach, S; Möller, B; Zwahlen, M; Villiger, PM; Dufour, Jean-François (2010). Hepatoprotective effect of tumour necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study. Annals of the rheumatic diseases, 69(6), pp. 1148-1150. London: BMJ Publishing Group 10.1136/ard.2009.116194
Dinges, S; Morard, I; Heim, M; Dufour, Jean-François; Müllhaupt, B; Giostra, E; Clavien, P-A; Mentha, G; Negro, F (2009). Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation. Transplant infectious disease, 11(1), pp. 33-9. Hoboken, N.J.: Wiley 10.1111/j.1399-3062.2008.00359.x
Dufour, Jean-François (2009). The evasive promise of antiangiogenic therapy. Journal of hepatology, 51(5), pp. 970-2. Amsterdam: Elsevier
Bochud, Pierre-Yves; Cai, Tao; Overbeck, Kathrin; Bochud, Murielle; Dufour, Jean-François; Müllhaupt, Beat; Borovicka, Jan; Heim, Markus; Moradpour, Darius; Cerny, Andreas; Malinverni, Raffaele; Francioli, Patrick; Negro, Francesco (2009). Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. Journal of hepatology, 51(4), pp. 655-66. Amsterdam: Elsevier 10.1016/j.jhep.2009.05.016
Balmer, Maria Luisa; Siegrist, Kathrin; Zimmermann, Arthur; Dufour, Jean-François (2009). Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis. Liver international, 29(8), pp. 1184-8. Oxford: Blackwell Munksgaard 10.1111/j.1478-3231.2009.02037.x
Lepper, P M; Dufour, Jean-François (2009). [Elevated transaminases - what to do if everything was done?]. Praxis - schweizerische Rundschau für Medizin, 98(6), pp. 330-4. Bern: Huber
Prasad, Leonie; Spicher, V M; Negro, F; Rickenbach, M; Dufour, Jean-François (2009). Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study. Journal of viral hepatitis, 16(9), pp. 644-649. Oxford: Blackwell Science 10.1111/j.1365-2893.2009.01113.x
Dufour, Jean-François; Pradat, Pierre; Ruivard, Marc; Hot, Arnaud; Dumontet, Charles; Broussolle, Christiane; Trepo, Christian; Sève, Pascal (2009). Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases. European journal of gastroenterology & hepatology, 21(3), pp. 245-53. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/MEG.0b013e3283249908
Roh, V; Laemmle, A; Von Holzen, U; Stroka, D; Dufour, Jean-François; Hunt, K K; Candinas, D; Vorburger, S A (2008). Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma. Cancer gene therapy, 15(10), pp. 636-44. New York, N.Y.: Nature Publishing Group 10.1038/cgt.2008.34
Romanque, Pamela; Stickel, Felix; Dufour, Jean-François (2008). Disproportionally high results of transient elastography in patients with autoimmune hepatitis. Liver international, 28(8), pp. 1177-8. Oxford: Blackwell Munksgaard 10.1111/j.1478-3231.2008.01743.x
Balmer, Maria Luisa; Dufour, Jean-François (2008). Treatment of hypercholesterolemia in patients with primary biliary cirrhosis might be more beneficial than indicated. Swiss medical weekly, 138(29-30), pp. 415-9. Muttenz: EMH Schweizerischer Ärzteverlag
Lenglet, Sébastien; Antigny, Fabrice; Vetterli, Laurène; Dufour, Jean-François; Rossier, Michel F (2008). Hint2 is expressed in the mitochondria of H295R cells and is involved in steroidogenesis. Endocrinology, 149(11), pp. 5461-9. Chevy Chase, Md.: Endocrine Society 10.1210/en.2008-0400
Strebel, Bruno M; Dufour, Jean-François (2008). Combined approach to hepatocellular carcinoma: a new treatment concept for nonresectable disease. Expert review of anticancer therapy, 8(11), pp. 1743-9. London: Expert Reviews 10.1586/14737140.8-11.1743
Helbling, B; Overbeck, K; Gonvers, J-J; Malinverni, R; Dufour, Jean-François; Borovicka, J; Heim, M; Cerny, A; Negro, F; Bucher, S; Rickenbach, M; Renner, E L; Mullhaupt, B (2008). Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection. Gut, 57(11), pp. 1597-603. London: BMJ Publishing Group 10.1136/gut.2007.142844
Martin, Juliette; Dufour, Jean-François (2008). Tumor suppressor and hepatocellular carcinoma. World journal of gastroenterology, 14(11), pp. 1720-33. Beijing (China): WJG Press 10.3748/wjg.14.1720
Romanque, Pamela; Piguet, Anne-Christine; Dufour, Jean-François (2008). Targeting vessels to treat hepatocellular carcinoma. Clinical science, 114(7), pp. 467-77. London: Portland 10.1042/CS20070310
Hora, Caroline; Negro, Francesco; Leandro, Giacchino; Oneta, Carl M; Rubbia-Brandt, Laura; Muellhaupt, Beat; Helbling, Beat; Malinverni, Raffaele; Gonvers, Jean-Jacques; Dufour, Jean-François (2008). Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C. Liver international, 28(3), pp. 370-6. Oxford: Blackwell Munksgaard 10.1111/j.1478-3231.2007.01608.x
Piguet, Anne-Christine; Semela, David; Keogh, Adrian; Wilkens, Ludwig; Stroka, Deborah; Stoupis, Christoforos; St-Pierre, Marie V; Dufour, Jean-François (2008). Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma. Journal of hepatology, 49(1), pp. 78-87. Amsterdam: Elsevier 10.1016/j.jhep.2008.03.024
Dufour, Jean-François (2007). Met-thodology. Journal of hepatology, 46(4), pp. 748-9. Amsterdam: Elsevier
Plock, Jan; Frese, Steffen; Keogh, Adrian; Bisch-Knaden, Sonja; Ayuni, Erick; Corazza, Nadia; Weikert, Christian; Jakob, Stephan; Erni, Dominique; Dufour, Jean-François; Brunner, Thomas; Candinas, Daniel; Stroka, Deborah (2007). Activation of non-ischemic, hypoxia-inducible signalling pathways up-regulate cytoprotective genes in the murine liver. Journal of hepatology, 47(4), pp. 538-45. Amsterdam: Elsevier 10.1016/j.jhep.2007.04.016
Chtioui, Haithem; Semela, David; Ledermann, Monika; Zimmermann, Arthur; Dufour, Jean-François (2007). Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis. Liver international, 27(6), pp. 764-71. Oxford: Blackwell Munksgaard 10.1111/j.1478-3231.2007.01524.x
Banz, Yara; Inderbitzin, Daniel; Seiler, Christian A; Schmid, Stefan W; Dufour, Jean-François; Zimmermann, Arthur; Mohaçsi, Paul; Candinas, Daniel (2007). Bridging hyperacute liver failure by ABO-incompatible auxiliary partial orthotopic liver transplantation. Transplant international, 20(8), pp. 722-7. Oxford: Wiley-Blackwell 10.1111/j.1432-2277.2007.00512.x
Dufour, Jean-François; Huber, Otmar; Kozma, Sara C; Lu, Xin; Toftgård, Rune (2007). Tumour suppressors in liver carcinogenesis. Journal of hepatology, 47(6), pp. 860-7. Amsterdam: Elsevier 10.1016/j.jhep.2007.09.003
Dufour, Jean-François (2007). NASH and thiazolidinediones: not to be taken lightly. Journal of hepatology, 47(4), pp. 451-453. Amsterdam: Elsevier 10.1016/j.jhep.2007.07.012
Semela, David; Piguet, Anne-Christine; Kolev, Mirjam; Schmitter, Karin; Hlushchuk, Ruslan; Djonov, Valentin; Stoupis, Christoforos; Dufour, Jean-François (2007). Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma. Journal of hepatology, 46(5), pp. 840-8. Amsterdam: Elsevier 10.1016/j.jhep.2006.11.021
Roth, Patrik; Hammer, Caroline; Piguet, Anne-Christine; Ledermann, Monika; Dufour, Jean-François; Waelti, Ernst (2007). Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2. Journal of drug targeting, 15(9), pp. 623-31. London: Informa Healthcare 10.1080/10611860701502723
Banz Wälti, Yara; Rieben, R; Inderbitzin, D; Seiler, C; Schmid, S; Dufour, Jean-François; Smith, R; Nydegger, U; Zimmermann, A; Mohacsi, P; Candinas, Daniel (2007). Immunological preconditioning, including local complement inhibition, in ABO-incompatible auxiliary partial orthotopic liver transplantation as a bridge to definitive grafting in hyperacute liver failure: First report of a successful strategy. Molecular immunology, 44(1-3), pp. 153-154. Amsterdam: Elsevier 10.1016/j.molimm.2006.07.020
Keogh-Stroka, Deborah M.; Trochsler, M; Hlushchuk, R; Baum, O; Candinas, Daniel; Dufour, Jean-François; Djonov, V (2007). Sinusoidal duplication by intussusception is an early event in liver regeneration after partial hepatectomy. Journal of hepatology, 46(46), S146. Amsterdam: Elsevier 10.1016/S0168-8278(07)61974-6
Piguet, A; Ledermann, C; Zimmermann, A; Keogh-Stroka, Deborah M.; Dufour, Jean-François (2007). Hypoxia worsens non-alcoholic steatohepatitis. Journal of hepatology, 46(46), S10. Amsterdam: Elsevier 10.1016/S0168-8278(07)61616-X
Dufour, Jean-François; Oneta, CM; Gonvers, JJ; Bihl, F; Cerny, A; Cereda, JM; Zala, JF; Helbling, B; Steuerwald, M; Zimmermann, A; Swiss, Association for the Study of the Liver (2006). Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clinical gastroenterology and hepatology, 4(12), pp. 1537-43. Philadelphia, Pa.: Elsevier 10.1016/j.cgh.2006.09.025
Barth, Florian; Gerber, Peter J; Reichen, Jürg; Dufour, Jean-François; Nicod, Laurent P (2006). Efficiency and safety of bosentan in child C cirrhosis with portopulmonary hypertension and renal insufficiency. European journal of gastroenterology & hepatology, 18(10), pp. 1117-9. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/01.meg.0000231749.60889.f7
Martin, Juliette; Magnino, Fabrice; Schmidt, Karin; Piguet, Anne-Christine; Lee, Ju-Seog; Semela, David; St-Pierre, Marie V; Ziemiecki, Andrew; Cassio, Doris; Brenner, Charles; Thorgeirsson, Snorri S; Dufour, Jean-François (2006). Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma. Gastroenterology, 130(7), pp. 2179-88. Philadelphia, Pa.: Elsevier 10.1053/j.gastro.2006.03.004
De Gottardi, Andrea; Dufour, Jean-François (2006). [Oesophageal and fundic variceal bleeding]. Therapeutische Umschau, 63(5), pp. 295-9. Bern: Huber
Dufour, Jean-François; Fey, Martin F (2006). What is the current treatment of PTLD after liver transplantation? Journal of hepatology, 44(1), pp. 23-6. Amsterdam: Elsevier 10.1016/j.jhep.2005.10.009
Keogh-Stroka, Deborah M.; Plock, Jan Alexander; Beldi, Guido; Frese, Steffen R.; Keogh, Adrian; Bisch-Knaden, Sonja Maria; Dufour, Jean-François; Brunner, Thomas; Candinas, Daniel (2006). Temporary hypoxic stress protects the liver from Fas-mediated apoptosis and ischemia reperfusion injury. In: 93. Jahreskongress der Schweizerischen Gesellschaft für Chirurgie. Lugano, Switzerland. 21.-23.6.2006.
Guenat, O T; Boulard, G; Dufour, Jean-François; de Rooij, N F; Koudelka-Hep, M (2004). Development of a multifunctional platform for extra- and intracellular ionic activities recording. IEEE Engineering in Medicine and Biology Society conference proceedings, 2004, pp. 2546-2548. Piscataway, N.J.: IEEE Service Center
Bissig, Karl-Dimiter; Zimmermann, Arthur; Bernasch, Dirke; Furrer, Hansjakob; Dufour, Jean-François (2003). Herpes simplex virus hepatitis 4 years after liver transplantation. Journal of gastroenterology, 38(10), pp. 1005-1008. Springer 10.1007/s00535-002-1186-0
